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Summary 
Membrane bound cytochrome b5 is a ubiquitous protein with an average molecular weight of 
16 kDa. The protein is involved in a number of reactions providing electrons directly to 
cytochrome P450 enzymes or to other enzymes involved in lipid biosynthesis. It is also 
known that the protein influences the activities of certain enzymes via an allosteric effect. It 
has been accepted in the literature that the cytochrome b5 exists primarily in the monomeric 
form, however, recently it has been shown that it forms homomeric complexes in vivo. In this 
study, we investigate the cytochrome b5 complex formation using a variety of analytical 
tools. Cytochrome b5 was isolated from ovine liver microsomes and the purity verified using 
sodium dodecyl sulphate polyacrylamide gel electrophoresis and electrospray ionisation mass 
spectrometry. The latter analysis confirmed the presence of a single heme containing protein 
with Mr=15865 Da, while separation on the polyacrylamide gel revealed oligomeric complex 
formation with the tetrameric form the most prominent oligomer. Using different and 
particularly harsh denaturing conditions we found that the observed oligomeric aggregates 
persisted, indicating highly stable complexes. The most prominent tetrameric aggregate was 
identified to be cytochrome b5 by mass spectrometric sequencing. Further complex formation 
studies, using a fluorescent dye (1-anilinonaphthalene-8-sulfonic acid) that interact with 
hydrophobic cavities formed during oligomerisation, provided evidence of protein assembly 
in oligomeric complexes or aggregation. The formation of the cytochrome b5 complexes was 
dependent on ionic strength and protein concentration. Previously it was shown that the 
hydrophobic membrane anchoring domain plays a pivotal role in the cytochrome b5’s 
homomeric complexes. Using a peptide (IITTIDSNSS), resembling a portion of this domain, 
together with circular dichroism we showed more organized structure present for the wild-
type peptide vs. a mutated control peptide (LLSSLKAVAV). A modified ELISA interaction 
assay also revealed that the wild-type peptide had a specific interaction with cytochrome b5, 
providing further evidence that the membrane anchoring domain plays a role in complex 
formation. These studies also indicated that a hydrogen bond network in this domain may be 
important for the formation of the homomeric complexes of cytochrome b5. 
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Opsomming 
Membraan-gebonde sitochroom b5 is ’n alomteenwoordige proteïen met ’n gemiddelde 
molekulêre massa van 16 kDa. Die proteïen is betrokke in reaksies waar dit elektrone direk 
aan sitochroom P450 ensieme verskaf, sowel as ensieme betrokke in lipiedbiosintese. Dit is 
ook bekend dat die proteïen die aktiwiteite van sekere ensieme via ’n allosteriese effek 
beïnvloed. Dit is geredelik in die literatuur aanvaar dat sitochroom b5 as ’n monomeer 
voorkom, maar daar is kort gelede gerapporteer dat homomeriese komplekse in vivo vorm. In 
hierdie studie is die sitochroom b5-kompleksvorming ondersoek deur gebruik te maak van 
verskeie analietiese metodes. Sitochroom b5 is vanuit skaaplewer mikrosome geïsoleer en die 
suiwerheid met behulp van natrium-dodesiel-sulfaat-poliakrielamied-gel-elektroforese en 
elektrosproei-ionisasie massa-spektrometrie geverifieer. Met die laasgenoemde bevestig dat 
’n enkele heem-bevattende proteïen met Mr =15865 teenwoordig was, terwyl poliakrielamied 
gel-skeiding kompleksvorming getoon het, met tetrameer as die mees prominente oligomeer. 
Deur verskeie denaturerings kondisies, intsluitend  besondere kondisies, is gevind dat hierdie 
aggregate behoue bly, wat baie stabiele oligomere aandui.  Die mees prominente tetrameriese 
aggregaat is as sitochroom b5 geïdentifiseer met behulp van massa spektrometriese 
volgordebepaling. Kompleksvorming is verder bewys deur ’n verdere ondersoek met behulp 
van ’n fluoresserende kleurstof (1-anilinonaftaleen-8-sulfoonsuur) wat met die hirdofobiese 
holtes, wat vorm tydens oligomermerisasie, interaksie het. Die kompleksvorming was 
afhanklik van ioniese sterkte, sowel as proteïenkonsentrasie. Voorheen was dit bewys dat die 
deurslaggewende faktor in die vorming sitochroom b5 se homomeriese komplekse die 
hidrofobiese membraan-anker-domein is. Deur gebruik te maak van ’n peptied 
(IITTIDSNSS) wat lyk soos ’n gedeelte van hierdie domein, tesame met sirkulêre 
dichroisme, is gewys dat meer georganiseerde struktuur teenwoordig was vir die wilde tipe 
peptied vs. ’n gemuteerde kontrole peptied (LLSSLKAVAV). ’n Gemodifiseerde ELISA-
interaksie-essai het ook getoon dat die wilde-tipe peptied spesifieke interaksie met 
sitochroom b5 het, ’n verdere bewys dat hierdie membraan-anker-domein ’n rol speel in 
kompleksvorming. Hierdie studies het ook aangedui dat ’n waterstofbinding netwerk in die 
domein belangrik kan wees vir die vorming van die homomeriese komplekse van sitochroom 
b5. 
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Chapter 1 
Prelude 
Cytochrome b5 is a small acidic protein which serves as an electron carrier for several 
biochemical reactions [1]. Two forms of cytochrome b5 exist in mammals, namely a smaller 
hydrophilic isoform (14.6 kDa) [2] mainly found in the erythrocytes, and a membrane bound 
form (15.2 kDa) [3], amphiphilic in nature containing both a hydrophilic and hydrophobic 
region, the latter being responsible for targeting the protein to the fluid membrane [1]. 
The heme containing cytochrome b5 serves as an electron carrier for several monooxygenase 
reactions [1]. During this catalysis the hemoprotein is believed to provide the second, rate 
limiting electron to a number of cytochrome P450-dependent enzymes. Furthermore, the 
protein also supplies electrons to certain desaturases in the production of unsaturated fatty 
acids during lipid biosynthesis [1]. 
The isolation of the cytochrome b5 has been previously reported in literature [4] and the 
molecular mass has been reported to be an average molecular weight of 15.263 kDa [3]. 
Lombard et al. [3] accurately determined the molecular weight of ovine cytochrome b5, using 
electrospray ionisation – mass spectrometry (ESI-MS), and indicated a molecular weight of 
15.263 Da. Furthermore, they reported that when isolating the protein from animal tissue a 
number of bands identified as protein multimers could be visualised using SDS gel 
electrophoresis (SDS-PAGE) [5]. When removing the membrane anchoring domain by 
trypsin digestion, these multimeric complexes were not observed. It was then concluded that 
the membrane anchoring domain plays an important role in the aggregation of the protein [6]. 
In this study, the complex formation of cytochrome b5 was further investigated. The goals of 
the study were the following: 
1. the isolation and characterization of ovine liver cytochrome b5,  
2. investigation of the aggregate formation, and 
3. investigating the region suspected to be responsible for aggregation using 
synthetic peptides. 
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This study to reach each of the goals is reported in five chapters as outlined below. 
Chapter 2 – Literature review 
In Chapter 2 of this thesis, a literature review is given on cytochrome b5. The structure of 
cytochrome b5 is discussed with special emphasis on regions important for activity and 
aggregation, including the hydrophilic N-terminus, the heme binding pocket and the 
orientation of the hydrophobic C-terminus and the linker domain between the hydrophilic and 
hydrophobic domains. In addition, the physical and the chemical properties are discussed in 
detail. Cytochrome b5 influences a number of cytochrome P450-dependent reactions and 
there are a number of mechanisms postulated on this cytochrome b5–cytochrome P450-
interaction. Chapter 2 also covers the four major hypotheses on cytochrome b5-cytochrome 
P450-interaction and discusses how cytochrome b5 influences specific cytochrome P450-
dependent enzymes as well as enzymes involved in lipid biosynthesis. 
 Chapter 3 - Isolation and characterisation of cytochrome b5 from ovine liver   
To investigate the aggregate formation and the region suspected for this phenomenon, full 
length cytochrome b5 had to be purified from ovine liver. In Chapter 3 the isolation of full-
length cytochrome b5 from ovine liver microsomes is described. The isolation was 
accomplished by solubilising the microsomal membranes, thereby releasing the membrane 
bound proteins. The subsequent purification of cytochrome b5 was achieved using ion-
exchange chromatography. The purified fraction was subjected to extensive dialyses and 
analysed using SDS-PAGE. Previous studies have reported the accurate mass of cytochrome 
b5 [3] and in this study the isolated protein was again subjected to high resolution 
electrospray mass spectrometry for accurate determination of its molecular weight. In order 
to achieve this, the amount of detergent left in solution was determined 
spectrophotometrically and trace amounts removed using commercially available spin 
columns. After solution clean-up, the accurate mass was determined which included the 
detection of its protoporphyrin IX heme group. The molecular mass detected correlated well 
with data previously reported in the literature [3]. 
 Chapter 4 - Aggregation studies on cytochrome b5 
Previous studies on cytochrome b5 showed that multimeric complexes are observed with 
SDS-PAGE. Chapter 4 describes the study in which these multimeric complexes were 
analysed using affinity purified immunoglobulins. The immunoglobulins recognising the 
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aggregated and monomeric forms of cytochrome b5 were isolated, by an immuno-affinty 
separation, and used in Western blot experiments. The various multimeric species of the 
purified protein were further analysed by SDS-PAGE and nano liquid chromatography mass 
spectrometry/mass spectrometry (nLC-MS/MS) using a peptide database. 
In addition cytochrome b5 aggregation was also investigated using a fluorescent dye. The dye 
molecules accumulate in hydrophobic pockets resulting in an increase in the fluorescence. 
 Chapter 5 – Investigating the region responsible for aggregation using a synthetic 
peptide 
Since it was demonstrated that the membrane anchoring domain plays a pivotal role in 
aggregate formation, it was decided to investigate this region using synthetic peptides. In 
Chapter 5, the aggregate formation was studied using circular dichroism and looking at 
differences in secondary structure of the commercially bought peptides. We investigated the 
effect of ionic strengths as well as different peptide concentrations. In addition to circular 
dichroism, the peptides were conjugated to biotin and this, in turn, was used for studying the 
interaction of immobilised cytochrome b5 with the biotinylated-peptides. For this, a 
technique commonly known as the ELISA was used whereby we immobilised purified 
cytochrome b5, added the biotinylated peptides and visualised the interaction 
spectrophotometrically.  
Chapter 6 - Final thoughts 
In Chapter 6 the findings of this study, based on the experimental data gathered, are discussed 
and future work is proposed. 
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Chapter 2 
2. Literature Review on Cytochrome b5 
2.1 Introduction 
Cytochrome b5 is a ≈16 kDa heme containing protein [7] capable of taking part in redox 
reactions by accepting and transferring a single electron [8]. The hemoprotein exists as two 
forms: a cytosolic soluble form, functioning in the maintenance of the oxygen-carrying 
capacity of haemoglobin, and a membrane bound form, affecting cytochrome P450 reactions, 
either through direct electron transfers [9] or as an effector [10].  
Cytochrome b5 was first observed more than five decades ago in microsomes and initially 
known as cytochrome m for their presence in microsomes [11]. It was found that this protein 
yielded an oxidised spectrum with a single absorbance in the Soret region at 414 nm. In the 
presence of a reducing agent, such as sodium dithionite, three major absorbance peaks could 
be observed, between 520 nm and 560 nm as well as at 424 nm. Unlike cytochrome P450 
these reduced spectra were unaffected by carbon monoxide [11].  
A number of forms of cytochrome b5 have been reported. These include forms with an 
average molecular weight of about 11 kDa [12], which were isolated through tryptic 
digestion. Another form of cytochrome b5, is the full-length form which was isolated from 
microsomes and which included reported molecular weights ranging 16 – 25 kDa [13]. 
Cytochrome b5 was isolated using detergents to solubilise membranes, releasing all 
membrane bound proteins. Recently, the accurate mass of cytochrome b5 was determined 
using ESI-MS and reported to be 15.263 kDa; excluding the protoporphyrin IX heme group 
[3], [6]. 
 It has long been reported that cytochrome b5 influences the activity of cytochrome P450-
dependent reactions. These enzymes are largely responsible for xenobiotic and drug 
metabolism. During catalysis, cytochrome P450 needs two electrons and two protons for 
complete activity. The first electron is provided by its redox partner, NADPH-cytochrome 
P450 reductase (CPR). This, in turn, raises the redox potential allowing the second electron 
source to either be CPR or cytochrome b5. Cytochrome b5 can also alter the activity of the 
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enzymes by playing a role as effector to cytochrome P450. It has been shown that 
cytochrome b5 may also have no effect on the activity of certain P450 enzymes [1]. 
2.2 Structure of cytochrome b5 
 2.2.1 The cytochrome b5 gene 
Two forms of cytochrome b5 exist, namely a soluble form and membrane associated form. 
The soluble cytochrome b5 is commonly found in erythrocytes and the membrane bound 
form is found embedded in the endoplasmic reticulum. The latter is known to be the full-
length form of the cytochrome b5 that is 133 amino acids in length, while the soluble form 
consists only of approximately 93 amino acids. The membrane bound form of the protein is 
depicted in figure 2.1. 
Using the complete nucleotide sequence of soluble cytochrome b5 chromosomal-DNA 
(cDNA) and a full-length protein cDNA clone for comparison,  Zhang et al. [14] concluded 
that both the forms of the protein were transcribed from the same gene. The bovine 
cytochrome b5 gene was first isolated and characterised in 1993 by Christiano et al. [15]. 
They found that the gene had a span of about 28 kb and contained six exons which included a 
non-functional exon at the fourth position. Moreover, the size and organization of the genes 
were found to be comparable to that of the human and rabbit cytochrome b5 genes. The gene 
was found to follow the GT-AG rule, which is the observation that all introns in DNA begin 
with the nucleotides GT (guanine and thymine) and end with AG (adenine and guanine). 
Also, a number of G:C-rich Spl motifs were observed. This observation was indicative of a 
housekeeping gene – a constitutive gene required for basic cellular function. All of these 
were observed on the 5’ flanking region further containing two CAAT boxes and lacking any 
TATA boxes [15]. The same was observed in the human gene [16]. 
Both Zhang et al. [14] and Christiano et al. [15] came to the same conclusion that only full-
length cytochrome b5 is expressed and that the soluble form is a result of post transcriptional 
modification. A protease, such as trypsin, cleaves the membrane binding domain releasing 
the soluble, functional globular domain. 
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Figure 2.1: Molecular model of the membrane bound form of cytochrome b5. Full length 
cytochrome b5 with the C-terminus spanning the fluid membrane [17].   
2.2.2 The hydrophilic N-terminus of cytochrome b5 
As mentioned, full-length cytochrome b5 is about 133 amino acids in length. The protein is 
susceptible to proteases such as trypsin and chymotrypsin. Once treated with proteases a 
shortened, intact functional hydrophilic domain of cytochrome b5 is produced. 
The three dimensional structure of this fragment was determined by Mathews et al. [18] who 
found that the small acidic protein was cylindrical in shape. The dimensions of this “head” 
domain were 35 Ǻ in height and 30 Ǻ in diameter. Furthermore, it was found that this domain 
contained six relatively short helices and a single β-sheet strand; the latter dividing the 
hydrophilic domain in two. The larger of the two domains contains four helices which consist 
of residues 21 through to 78. The larger domain also houses the heme group allowing the 
domain to participate in electron transfer reactions [18]. 
 2.2.3 Coordination of the heme-group 
The soluble N-terminus of cytochrome b5 contains a hydrophobic crevice which houses the 
porphyrin ring and iron group (heme group). It is buried within the protein with the propionic 
acid groups facing the surface of the protein. Only part of these propionate groups are in 
contact with solvent. There are 14 side chains in contact with the heme group, with almost 
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80% of it being hydrophobic [18]. In animals, this heme is coordinated by two highly 
conserved histidine residues situated at positions 44 and 68. These histidine residues are 
aligned in an axial position to the heme group, with both heme-linked histidine side chains 
perpendicular to the porphyrin ring. The δ-nitrogens, which are hydrogen bound, form 
hydrogen bonds with main chain carbonyl oxygens [18]. The two ε-nitrogens of these 
residues are approximately 2.0 Ǻ from the iron group [19] forming a dative covalent bond 
between the iron and the nitrogen. This observation is in contrast to data published by Nunez 
et al. [20] who found in their tertiary structure calculations that the heme is covalently bound. 
It was found that there are no significant changes in the protein structure between oxidised 
cytochrome b5 and sodium dithionite reduced cytochrome b5. Some differences which were 
observed were that, in the presence of the reducing agent, it introduced a cation at the mouth 
of the hydrophobic pocket. Furthermore, to accommodate the binding of the cation, a slight 
movement of an adjacent lysine side chain was also observed. Argos and Mathews [19] went 
on to explain the significance of this cation. They concluded the reason for oxidised 
cytochrome b5 binding more strongly to cytochrome b5 reductase than reduced cytochrome 
b5, could be the fact that the cation, on the reduced cytochrome b5, could interfere with ionic 
attraction resulting in a decrease in charge pairing.  
 2.2.4 Structure of the linker 
The linker domain is a short peptide, consisting of 14 amino acids, linking the membrane 
binding domain to the hydrophilic heme-containing domain. Little is known about the 
structure of the linker domain, which was first reported by Muskett et al. [21]. In a more 
recent study of the structure of cytochrome b5 [20] it was reported, using a construct 
consisting only of the globular head and the linker domain, that the linker domain had no 
secondary structure. Nunez et al. [20] also stated that the lack of structure observed in their 
studies could be due the fact that they were using a shortened version of the protein, rather 
than the full-length.  Muskett et al. [21] found, using full-length cytochrome b5, that the 
linker was in an extended unfolded conformation. There is consequently still an uncertainty 
on the conformation and structure of the linker domain. 
2.3 Distribution of cytochrome b5 
Cytochrome b5 is a hemoprotein which is most abundant in the liver. Ichikawa and Yamano 
[22] reported cytochrome b5 to be found in the Golgi membranes of mammalian livers. They 
found that the cytochrome b5 content was relatively high, while other enzymes (cytochromes 
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P450) are low. Also, it was found that the cytochrome b5 from these Golgi membranes yields 
a similar absorption spectrum as cytochrome b5 found in microsomes [22]. 
Apart from the liver, relatively high expression of cytochrome b5 is observed in the adrenal 
cortex. The adrenal cortex has been recognised to be responsible for the output of androgenic 
steroids [23]. The adrenal cortex is organised into three zones: an outer zone which is 
referred to as the zona glomerulosa, the middle zone known as the zona fasiculata and the 
most inner zone called the zona reticularis [24].  Mapes et al. [25] are believed to be the first 
to report the regional expression of cytochrome b5 in adrenals. They observed that 
cytochrome b5 was expressed only in the zona reticularis and was expressed together with 
cytochrome P450c17 (P450c17) and cytochrome P450 reductase and low levels of 3β-
hydroxysteroid dehydrogenase/∆5-∆4 isomerase (3βHSD). In contrast to their findings, 
immunohistochemical studies by Engelbrecht [26] showed otherwise. Using a polyclonal 
antibody, raised against cytochrome b5 purified from ovine liver, cytochrome b5 was mainly 
detected in the zona fasiculata. Furthermore, cytochrome b5 was also unexpectedly detected 
in a cross section of the adrenal medulla. Engelbrecht [26], however, stated that latter finding 
could also be due to cross reactivity of the polyclonal antibody to a contaminating protein in 
the antigen preparation used to raise the antibodies. 
2.4 Properties of cytochrome b5 
2.4.1 Spectral properties of cytochrome b5 
Like any other protein cytochrome b5 absorbs in the ultraviolet region. In addition, the 
protein also has an absorbance in the Soret region of the spectrum. Oxidised cytochrome b5 
exerts an absorbance maximum in this visible region between 409 nm and 413 nm. 
Cytochrome b5 in a microsomal suspension can be rapidly reduced through the addition of a 
reducing agent, such as NADH. Upon reduction of cytochrome b5, the absorbance maximum 
is shifted from 413 nm to 426 nm. This shift is accompanied by the appearance of a further 
two peaks at 556 nm and 575 nm [27].  
Spectral properties of cytochrome b5 are not only a useful tool for identification of the 
protein but can also be used to determine the molar concentration of the protein in a solution. 
The cytochrome b5 concentration can be determined using the change in absorbance at 426 
and 409 nm together with an extinction coefficient of 185 mM-1cm-1. Alternatively, the 
appearance of the additional two peaks can also be used for the same purpose. This is done 
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by using the difference between the absorbance at 556 -and 575 nm and an extinction 
coefficient of 21 000 M-1cm-1. The same principle can be applied for the determination of 
cytochrome b5 content within a purified fraction. This is accomplished through the addition 
of sodium dithionite as reducing agent as it can reduce cytochrome b5 directly, in the absence 
of cytochrome b5 reductase [27]. 
2.4.2 Stability of cytochrome b5 
The isolation of the membrane bound form of cytochrome b5 has been reported by Yang and 
Cederbaum [4]. This involves the preparation of microsomes through dehydration, which 
results in the formation of membranous vesicles. The stability of cytochrome b5 in a 
microsomal preparation has been investigated. The effects of freezing and storage of these 
preparations was reported by Pearce et al. [28], who found that longterm storage of 
microsomes had no significant influence on the activity of cytochrome b5. This long term 
storage included flash freezing, using liquid nitrogen, and storage for up to 6 months at 
−80°C. Also, long term storage of up to 2 years of cytochrome b5 in 250 mM sucrose at 
−80°C did not affect the concentration of protein when determined spectrophotometrically, 
concluding that cytochrome b5 within microsomes are relatively stable over long periods of 
storage. 
The thermal stability of cytochrome b5 was investigated by Newbold and Whitford [29]. 
They reported that the full-length cytochrome b5 exhibited two transition states between a 
folded and an unfolded state over a temperature range of 5 – 95°C. These transitions were 
detectable at 43.4 and 71°C. Conversely, only a single transition was observed at 73°C for the 
truncated form of the protein. It was also reported that the addition of a mild detergent, such 
as Triton X-100, considerably lowered the melting point of the full-length version. What was 
also of note was that, as the concentration of the Triton X-100 was increased, the melting 
point decreased. Another effect of the detergent was the induction of a single, smoother 
transition between 40°C and 50°C [29].  
Mitochondrial membrane cytochrome b5 are, amongst the different forms, the most thermal 
stable isoform of the protein known. Conversely, during the studies of Wang et al. [30], only 
a single transition state could be observed for mitochondrial membrane and microsomal 
cytochrome b5. These states were observed at higher temperatures well above 70°C. 
Furthermore, they reported that the thermal stability could be advanced by swapping an 
invariant motif in the heme-independent folding core with a motif of that of a less stable 
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microsomal cytochrome b5 isoform. This involved the substitution of Arg15 and Glu20 with 
histidine and serine respectively [30]. 
The effect of ionic strength on the stability of cytochrome b5 was reported by Schenkman 
[31]. Ionic strength plays a role in the interactions of cytochromes P450 with cytochrome b5, 
albeit to a lesser extent. It was shown that at higher ionic strength the interaction between 
cytochrome b5 and cytochrome P450 was diminished. Also, at low ionic strength the rate 
constant for cytochrome b5 reduction was increased 15-fold.   
2.4.3 Membrane topology of cytochrome b5 
Cytochrome b5 is embedded into the membrane of the endoplasmic reticulum (ER) via the C-
terminus, unlike its redox partner and all other cytochromes P450 which are anchored via the 
N-terminus. The protein is synthesised on cytosolic ribosomes and was found to be inserted, 
post-transcriptionally, into the microsomal membranes. The insertion happens independently, 
without the use of any signal recognition particle [32]. This was observed when adding 
cytochrome b5 to microsomes which bound to the membrane in the presence of sodium 
carbonate, pH 11.5 containing 500 mM NaCl.  
To determine whether the C-terminus spanned the lipid bilayer, or was located in the cytosol, 
Ozols [33] treated microsomes with trypsin and isolated the resulting hydrophobic peptides 
using gel filtration and HPLC to investigate this phenomenon. The amino acid sequence of 
cytochrome b5 contains a proline hinge region which is susceptible to the protease, trypsin 
[18]. Their findings suggested that cytochrome b5 is inserted into the lipid bilayer and that 
the hydrophobic domain contains a “hair-pin loop” resulting in the C-terminus to be in the 
same environment as that of the catalytic domain – the cytosol [33].  
In contrast to these findings, Vergères et al. [34] reported that the membrane binding domain 
of cytochrome b5 spans the microsomal membrane and that the C-terminus is located in the 
lumen and not the cytosol. In their studies it was suggested that if the membrane binding 
domain spans the membrane, only the Lys93 (located in the cytosol) would be exposed for 
trypsin digestion and the other site, Arg127, would be protected within the lumen. If this was 
the case, trypsin treatment would result in the single peptide, Pro94 – Asp133, which would 
have a calculated molecular mass of 4.6 kDa. Otherwise, if both trypsin cleavage sites were 
exposed and accessible to trypsin, suggesting the hair-pin loop, it would result in a peptide 10 
amino acids shorter and about 3.8 kDa in size. SDS-PAGE revealed that only the 4.6 kDa 
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peptide could be detected when cytochrome b5 was added to the microsomal membrane, but 
a shorter peptide could also be detected when digesting cytochrome b5 in the absence of 
membrane. Furthermore, carboxypeptidase Y had access to the C-terminus when cytochrome 
b5 was in solution but not when inserted into the membrane. These findings suggested that 
cytochrome b5 is inserted into the membrane with its C-terminus located in the lumen and 
not in a hair-pin loop configuration as suggested by Ozols [33] [34]. 
2.5 Mechanism of action 
Cytochrome b5 assists in the catalyses of a number of reactions in steroidogenesis and the 
metabolism of xenobiotics within the liver. It has been shown that cytochrome b5 does this 
either through a direct electron transfer reaction (supplying a single electron to cytochrome 
P450 enzymes) or through an allosteric effect [1]. The manner in which cytochrome b5 
enhances P450 enzyme activities is very important and little is known about its mechanism of 
action. A few mechanisms that have previously been postulated, discussed by Schenkman et 
al. [1] are summarised below.  
 2.5.1 Faster input of the second, rate limiting electron 
All cytochrome P450 monooxygenase reactions require the input of two electrons during the 
conversion of substrate to product, via the insertion of a single molecular oxygen into the 
substrate. Cytochrome P450 enzymes are limited in that they can only accept a single 
electron at a time [35]. This electron is provided by NADPH via its redox partner, 
cytochrome P450 reductase. CPR reduces ferric cytochrome P450 to its ferrous state. The 
ferro-cytochrome P450 complexes with oxygen, forming an unstable oxy-ferro cytochrome 
P450 complex. This complex can readily dissociate resulting in the release of superoxide 
species which, subsequently, can further react forming hydrogen peroxide if a second 
electron is not introduced into the system. After the reduction of cytochrome P450 and 
complexation with oxygen, the complex midpoint potential for reduction is raised from a 
reported  −230 mV to +50 mV [36]. With a midpoint potential of +5 mV, this makes 
cytochrome b5 a perfect candidate to provide the second rate limiting electron for the 
cytochrome P450 catalytic cycle to be completed. Figure 2.2 depicts this postulated 
mechanism of action [1]. 
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Figure 2.2: Supply of the second, rate limiting electron by cytochrome b5. Cytochrome b5 
provides the rate limiting electron which promotes product formation rather than 
the dissociation of the oxy-ferro cytochrome P450 complex (leading to H2O2 
formation) [1].  
  2.5.2 Prevention of uncoupling between cytochrome P450 enzymes and substrates 
As discussed earlier, the oxy-ferro cytochrome P450 complex is very unstable and, when not 
reduced in time, results in the formation of superoxides; leading to the increase of hydrogen 
peroxide. Imai et al. [37] showed that the presence of cytochrome b5 improves NADPH 
oxidation through substrate oxidation. Gorskys et al. [38] demonstrated, by adding 
cytochrome b5, that they could increase the rate of product formation without the release of 
superoxides, thus decreasing the formation of hydrogen peroxide (figure 2.3). It was 
suggested by the authors that cytochrome b5 plays a vital role in providing the second 
electron faster than the release of the superoxides (uncoupling) thereby allowing the 
formation of more product [38] . 
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Figure 2.3: Schematic representation of coupling enhancement by cytochrome b5. The solid 
lines show the path the reaction would follow if cytochrome b5 is present 
(coupling) and the dashed line depicts the superoxide formation in absence of 
cytochrome b5 (uncoupling) [1].  
 2.5.3 Formation of a two-electron acceptor complex with cytochrome P450 
As mentioned previously, there are two electrons needed for monooxygenase reactions 
catalysed by cytochrome P450 and it is accepted that cytochrome b5 provides the second, rate 
limiting electron. Although cytochrome b5 can accept an electron from NADPH-CPR, this is 
at a much slower rate than from its natural partner NADH-cytochrome b5 reductase [1]. 
Furthermore, Lu et al. [39] showed that NADH failed to further enhance the metabolism of 
chlorobenzene by cytochrome P450. This suggested that the supply of the rate limiting 
electron is not the problem.  
Cytochrome b5 is able to form a hetero-complex with both redox partners, CPR and 
cytochrome b5 reductase, which is made possible through charge pairing [40]. Cytochrome 
b5 can also form these hetero-dimeric complexes with various cytochrome P450’s, and it was 
shown that, when covalently linked, the complex is still fully functional [1]. In addition, 
when cytochrome b5 was covalently bound to cytochrome P450 2B4, NADH-cytochrome b5 
reductase was unable to reduce cytochrome b5. This suggested that interaction of cytochrome 
b5 with redox partners, when bound to cytochrome P450’s, is blocked [41]. Knowing that 
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when cytochrome b5 is complexed with cytochrome P450 it still is a functional complex, but 
also that cytochrome b5 is unable to accept electrons when complexed, it was postulated that 
the cytochrome b5-cytochrome P450 complex forms a two electron acceptor complex 
capable of accepting two electrons from a single interaction from CPR. As shown in figure 
2.4, cytochrome b5 interacts with cytochrome P450 through charge pairing. The latter 
enzyme can be readily reduced by NADPH-CPR to its ferrous state. This electron can 
immediately be passed to cytochrome b5 making cytochrome P450 available to accept a 
second electron from its redox partner. The complex, together with its two electrons, 
dissociates from the CPR and reacts with oxygen having the second electron immediately 
available from cytochrome b5.  
 
Figure 2.4: Schematic representation of cytochrome b5 and cytochrome P450 forming a two-
electron acceptor complex. In a single interaction with CPR two electrons can be 
passed to the hetero-dimeric complex [1]. 
 2.5.4 Structural influences caused by cytochrome b5 binding 
During the metabolism of xenobiotics cytochrome b5 can stimulate these reactions through 
electron transfer in a number of these oxidative reactions. Moreover, it has been shown that 
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cytochrome b5 can influence monooxygenase reactions without the transfer of a single 
electron. For instance, during the metabolism of steroids within the adrenal cortex, 
cytochrome b5 stimulates the 17,20 lyase activity of P450c17 [42]. Auchus et al. [42] showed 
that the apo-cytochrome b5, cytochrome b5 void of heme and incapable of transferring 
electrons, was as effective as holo-chytochrome b5. Similarly, in experiments using 
cytochrome P450 3A4, Imaoka et al. [43] came to the same conclusion which was that the 
binding of cytochrome b5 to certain cytochrome P450 enzymes causes structural influences 
which impacts on the ability of the monooxygenase reaction to undergo redox changes. More 
recently, Goosen et al. [44] provided evidence which shows that cytochrome b5 is not only 
an effector for cytochrome P450’s, but also for the enzyme 3βHSD. The investigators 
showed that apo-cytochrome b5 was able to augment the activity of the enzyme. Cytochrome 
b5 is, however, also known to be a heme scavenger which led the author to produce a mutant 
variant which was incapable of binding heme. This mutant could still influence the 3βHSD 
activity and the authors concluded that cytochrome b5 had an allosteric role rather than an 
electron transfer role in the augmentation of 3βHSD-activity [44]. Figure 2.5 shows a 
schematic representation of the role cytochrome b5 might play in direct allosteric interactions 
with cytochrome P450. 
 
Figure 2.5: Schematic representation of the role of cytochrome b5 as an allosteric effector. 
When bound to cytochrome P450 it causes a conformational change which can 
facilitate in product formation [1].  
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2.6 Functions of Cytochrome b5 
2.6.1 Role in steroidogenesis 
2.6.1.1 Cytochrome b5 and 3β-hydroxysteroid dehydrogenase/∆5-∆4 isomerase 
During adrenal steroid metabolism, metabolites of the ∆5-pathway are converted to the 
products of the ∆4-pathway by the enzyme 3β-hydroxysteroid dehydrogenase/∆5-∆4 
isomerase (3βHSD). These metabolites pregnenolone and dehydroepiandrosterone are 
converted to progesterone and androstenedione [45] and 17-hydroxypregnenolone to 17-
hydroxyprogesterone [46] indicating that 3βHSD plays a crucial role in adrenal steroid 
output. 
As previously discussed, it has long been known that cytochrome b5 can either enhance 
reactions through direct electron transfers or as an allosteric effector. Recently, our laboratory 
showed that cytochrome b5 has an effect on the activity 3βHSD. Goosen et al. [44] found 
that cytochrome b5 augments the activity of 3βHSD. They showed that cytochrome b5 
increased the conversion of all metabolites of the ∆5-pathway to their respective products in 
the ∆4-pathway. It was postulated that the method of augmentation is not through electron 
transfer but through an allosteric effect as apo-cytochrome b5 had a stimulatory effect on the 
activity of 3βHSD. In addition, this stimulatory effect was not due to a random, non-specific 
membrane effect. Stimulation of 3βHSD-activity was also achieved using the truncated 
version of the protein, a mutation which contained a shortened C-terminus and therefore 
lacking the membrane anchoring domain.  This finding together with the fact that 3βHSD 
does not need any electrons from an external electron donor, led the authors to suggest that 
the augmentation was due to an allosteric effect of cytochrome b5 on 3βHSD [44][46], like in 
the case with P450c17 [42].  
Recently, additional evidence was reported for the augmentation of 3βHSD activity by 
cytochrome b5. Fluorescence resonance energy transfer (FRET) studies revealed that the co-
expression of 3βHSD and cytochrome b5 fluorescent constructs had a significant increase in 
the FRET signal. This finding suggests that the these two enzymes indeed formed hetero-
dimeric complexes further confirming that the augmentation was due to an allosteric 
interaction [46]. 
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Goosen et al. [46] went on to demonstrate that, using purified enzymes, the presence of 
cytochrome b5 increased 3βHSD’s affinity for NAD+, the cofactor needed for the activity for 
the dehydrogenase reaction of the enzyme [47]. During the metabolism of ∆5-metabolites, 
the substrate together with NAD+ binds to 3βHSD resulting in the formation of a ∆5-3 
ketosteroid intermediate and NADH; both of which remain bound to the enzyme. NADH 
causes a conformational change in the enzyme which results in the isomerisation of the 
intermediate [48]. When cytochrome b5 was added the Km decreased more than threefold and 
the presence of the hemoprotein also increases the Vmax apparent by 17%. These data suggested 
that cytochrome b5 increased the 3βHSD affinity for its cofactor NAD+ [46]. 
  2.6.1.2 Cytochrome b5 and Cytochrome P450c17 
During adrenal steroidogenesis cholesterol is converted pregnenolone by the cytochrome 
P450 11A1, commonly known as P450 side chain cleavage. As discussed earlier, 
pregnenolone serves as a substrate for two enzymes: 3βHSD and cytochrome P450c17 
(P450c17). The former is responsible for the conversion of pregnenolone to progesterone and 
the latter is a multifunctional enzyme having both a hydroxylase and a lyase activity. During 
its hydroxylase activity, P450c17 introduces a hydroxyl group at the 17α-position of 21-
carbon steroids such as pregnenolone and progesterone resulting in the production of 17-
hydroxy-pregnenolone (17α-OH-PREG) and 17-hydroxy-progesterone (17α-OH-PROG), 
respectively. Moreover, both the products of the hydroxylase reaction are substrates for the 
17,20-lyase reaction catalysed by the same enzyme, P450c17. During this reaction, P450c17 
catalyses the 17,20-lyase reaction by cleaving the C17 – C20 bond of 17α-OH-PREG and 17α-
OH-PROG forming C19 sex steroid precursors, dehydroepiandrosterone (DHEA) and 
androstenedione (A4). This 17,20-lyase activity takes place at a much slower rate than its 
hydroxylase activity [49]. 
Although this reaction is  slow compared to the hydroxylase activity, it has been shown that 
cytochrome b5 augments the 17,20-lyase reaction [50] without affecting the hydroxylase 
activity of P450c17 [10]. Furthermore, the 17,20-lyase activity is known to be relevant to the 
androgen production. Auchus et al. [10] showed that by expressing P450c17, in 
Saccaromysces cerevisiae, without its redox partner, both the hydroxylase and 17,20-lyase 
activities could be observed with the latter to a lesser extent. Upon the addition of its redox 
partner they found that the Vmax of both reactions increased more than fivefold. On co-
expression of human cytochrome b5 the authors found that cytochrome b5 only increases the 
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Vmax of the 17,20-lyase activity of P450c17 without having any effect on its hydroxylase 
activity. The same effect was observed when adding purified cytochrome b5 to a microsomal 
preparation. When adding apo-cytochrome b5, a form of the protein void of heme and 
incapable of participating in electron transfer reactions, a similar effect could be observed. 
Furthermore, Lee-Robichaud et al. [51] found that using Mn2+-substituted cytochrome b5 the 
17,20-lyase activity could be stimulated two to fourfold; even though this form of the protein 
stays almost completely in the oxidised form in the presence of both NADPH:CPR and 
NADH:cytochrome b5 reductase. Omitting the option that the stimulation of cytochrome b5 
is through electron transfer, it is to date generally accepted that cytochrome b5 enhances the 
17,20-lyase activity of P450c17 allosterically [42]. Similar allosteric roles of this protein 
have been reported, examples include its affect on cytochrome P450’s 2A6, 2B6, 3A4 [52] 
and more recently 3βHSD [44].     
A second form of cytochrome b5 has been characterised [53]. Cytochrome b5 type 2 shared 
about 45% sequence identity and was an additional 15 amino acids longer than the full-length 
cytochrome b5. This addition was noted at the amino terminus. Soucy [53] reported that, in a 
reconstituted system, the 17,20- lyase activity of P450c17 could also be stimulated by the 
addition of this type 2 cytochrome b5. It was also reported that this type of cytochrome b5 is 
not only expressed in the liver, but in both the adrenal glands and the testis. 
 2.6.2 Ellipticine metabolism is altered by cytochrome b5 
Ellipticine is a drug which is taken orally. Once ingested, the alkaloid is taken up in the 
intestine and delivered to the liver; the organ responsible for metabolism of foreign 
molecules, where after it is metabolised by cytochrome P450 enzymes to a number of 
derivatives.  Some of the resulting metabolites are efficient anticancer compounds capable of 
forming highly reactive carbonium ions which can further react resulting in the formation of 
DNA adducts [54]. These adducts are predominantly responsible for targeting and killing 
cancer cells through apoptosis and cell cycle arrest. Cell cancers include: leukemias, 
lymphosarcomas, lung carcinomas and breast adenocarcinomas [55] [54]. 
Metabolised by cytochrome P450 3A4, the metabolites formed are 13-hydroxyellipticine, 12-
hydroxyellipticine and ellipticine-N2-oxide [54]. The latter metabolite can form 12-
hydroxyellipticine through Polonovski rearrangement. The 12 –and 13-hydroxyellipticine can 
readily dissociate to ellipticine-12-ylium and ellipticine-13-ylium respectively, which in turn 
are able to bind to guanine of DNA forming deoxyguanosine adducts [54]. The reaction for 
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the production of these two major products can also be catalysed by enzymes cytochrome 
P450 1A1 and/or 2 [54]. 
Recently it has been reported that cytochrome b5 not only alters the amounts of metabolites 
produced but also the type of metabolites formed [56]. Cytochrome P450 1A1/2 are capable 
of either detoxifying ellipticine forming 7– and 9-hydroxyellipticine. These metabolites are 
incapable of forming DNA adducts leading to a lower efficacy of the drug. The authors 
showed that, in the presence of cytochrome b5, the major metabolite observed was 13-
hydroxyellipticine. As mentioned previously, this metabolite can further react and form DNA 
adducts [56]. The same observation was made by Frei et al. [55] who reported that DNA 
adduct formation was enhanced by cytochrome b5. Cytochrome b5 was then suggested of 
being capable of switching certain cytochrome P450 enzymes from detoxification of 
ellipticine to formation of more active metabolites, in turn causing apoptosis, therefore 
making cytochrome b5 a modulator of the efficiency of the anticancer drug [56]. 
 The mechanism by which cytochrome b5 modulates the activity of these cytochrome P450 
enzymes is not clearly understood. Studies by Kotrbová et al. [56] found that holo-
cytochrome b5 had a more significant effect than apo-cytochrome b5. Furthermore, using 
manganese substituted cytochrome b5 yielded similar results as that of the apo-form, 
suggesting that enhancement could be due to the input of the rate-limiting electron. What is 
important to note, is that it has been reported that apo-cytochrome b5 and Mn-protoporphyrin 
IX co-exists in solution [57]. The investigators did not dismiss a structural role of cytochrome 
b5, the reason being that holo –and apo-cytochrome b5 differ in three dimensional structure. 
The former consisting of four helices and three loops while the latter only contains a single 
helix. This causes significant structural changes in the surface geometry of cytochrome b5 
preventing adequate protein-protein interaction. It was suggested that more studies regarding 
this matter should be completed [56]. 
 2.6.3 Reduction of methaemoglobin by cytochrome b5 
Haemoglobin is a hemoprotein responsible for carrying molecular oxygen from respiratory 
organs to the rest of the body. During the day a small percentage of oxygen-binding 
haemoglobin is oxidised to non-functional methaemoglobin [58]. Soluble cytochrome b5 is a 
smaller form of cytochrome b5 lacking the membrane binding domain. Although it is 
structurally different from the full-length form, the two proteins are functionally similar; 
exhibiting the same absorption spectra [59]. 
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Abe and Sugita [60] reported the midpoint potential of the soluble form of cytochrome b5 to 
be -2 mV. Despite this relatively low redox potential and low abundance cytochrome b5 
could sufficiently reduce methaemoglobin. It was reported that the soluble form of the 
protein had a similar affinity for its redox partner than that of full-length cytochrome b5 
solubilised using trypsin. The optimum pH for this reduction was found to be around 5.5 
under aerobic conditions. The presence of cytochrome b5 increased the rate of reduction of 
methaemoglobin considerably. However, what was observed was that at a neutral pH this 
reduction potential declined significantly. Furthermore, it was reported that this reduction 
was dependent on the presence of cytochrome b5 reductase. In the absence of this redox 
partner no reduction of methaemoglobin was observed [60]. 
  2.6.4 Lipid Biosynthesis 
Cytochrome b5 is involved in lipid biosynthesis through its interaction with desaturases; the 
enzymes responsible for synthesizing unsaturated fatty acids [1]. These fatty acids are found 
not only in animals, but also in plants and bacteria. Animals use the aerobic pathway for the 
synthesis of these fatty acids and cytochrome b5 donates a single electron to these 
desaturases. These enzymes utilise this electron to generate an electron-deficient, activated 
oxygen species which in turn reacts with saturated hydrocarbons, removing electrons from 
them. There are a number of desaturases which are involved in synthesising different 
unsaturated fatty acids which serve a structural role in membrane fluidity. A few examples of 
these desaturases are ∆9-, ∆6-, ∆12- and ∆5 desaturases. The ∆9 desaturases are the most 
completely characterised while the ∆5 desaturases are the least characterised and each 
functioning through the insertion of a double bond into their respective positions, given in 
their names [1]. 
 Phosphoglycerides, better known as plasmalogens, are vinyl-ether linked fatty alcohols 
which make up 20% of the phospholipid mass in humans alone. The final step in the 
biosynthesis of plasmalogens involves the introduction of a cis-double bond forming a vinyl-
ether functionality. The enzyme, plasmanylethanol-amine ∆-desaturase, is responsible for this 
catalysis and is totally dependent on cytochrome b5 [1]. 
2.6.5 Cholesterol Biosynthesis 
During the biosynthesis of cholesterol, lanosterol is converted to steroid-4α-oic acid through 
the oxidation of the C-30 methyl group. The enzyme responsible for the oxidation reaction is 
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4-methyl sterol oxidase. This enzyme functions through the oxidation of the C-30 group of a 
cholesterol precursor. Once oxidised to a steroid-4α-oic acid, it can subsequently be 
decarboxylated [9].  Cytochrome b5 provides reducing equivalents to the sterol oxidase for 
functionality. Upon the addition of anti-cytochrome b5 immunoglobulins it was observed that 
4-methyl sterol oxidase was inhibited by up to 50% [1]. It was demonstrated, in a 
reconstituted microsomal system, that when cytochrome b5 is treated with trypsin the 
enzyme’s oxidase activity is abolished. The oxidase activity, however, was completely 
restored after the same trypsin treated microsomes were washed and purified cytochrome b5 
was added to the same reconstituted system. This evidence suggested that the membrane 
bound form of cytochrome b5 is an obligatory electron carrier to microsomal 4-methylsterol 
oxidase [61]. 
Another precursor in cholesterol biosynthesis is ∆7-cholesterol (lathosterol). The enzyme 
lathosterol ∆5-desaturase catalyses the formation of a double bond between carbons 
positioned at numbers 5 and 6, producing ∆7-dehydrocholesterol. Grinstead and Gaylor [62] 
isolated this enzyme chromatographically using different stationary phases. Using a DEAE-
cellulose resin for purification of detergent solubilised microsomal suspension yielded a 
fraction which contained the desaturase, phospholipid and cytochrome b5 reductase. Activity 
of this enzyme was only noticed after introduction of cytochrome b5 to this fraction. An 
additional chromatographic purification step of this fraction, using Sepharose CL-4B resin, 
resulted in a fraction containing only the desaturase and cytochrome b5 reductase. This 
fraction showed activity when both cytochrome b5 and the phospholipid were added. The 
authors concluded that for optimal activity of lathosterol ∆5-desaturase both cytochrome b5 
and its redox partner were necessary [62]. 
 2.6.6 The effect of Cytochrome b5 on other Cytochromes P450 
In literature it is known that cytochrome b5 can stimulate, inhibit or have no effect on P450 
enzymes. It does this either through delivering the second, rate limiting electron during 
monooxygenase reactions or via an allosteric interaction [1]. Cytochrome b5 is known to 
effect up to 20 different P450 enzymes and a few examples will be discussed. 
 2.6.6.1 Cytochrome P450 2B4 
Xenobiotics such as cyclohexane and benzphetamine are metabolised by the P450 enzyme, 
cytochrome P450 2B4, to cyclohexanol and norbenzphetamine respectively. It was initially 
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believed that cytochrome b5 stimulates the activity of this enzyme through donation of the 
second electron [63], but further studies have suggested that both the electron donating and 
effector function of cytochrome b5 enhances the activity of cytochrome P450 2B4 [64]. 
Zhang et al. [65] reported that, under steady-state conditions, cytochrome b5 not only 
increases the rate of product formation, but also competes with cytochrome P450 reductase 
for binding on the P450 enzyme. It is hypothesised that if cytochrome b5 competes with CPR 
for binding, it would be observed in the decrease in NADPH consumption resulting in a 
decrease in product formation. This was indeed the case.  By having fivefold more 
cytochrome b5 than CPR, NADPH consumption and product formation was depleted more 
than 90%. Furthermore, the rate of oxidation of benzphetamine to norbenzphetamine, in the 
presence of cytochrome b5 alone, was found to be 18 s-1, whilst in the presence of CPR it was 
about 100-fold slower; 0.15 s-1 [65]. 
2.6.6.2 Cytochrome P450 2C9 
Another member of the P450 enzyme family which will be discussed is cytochrome P450 
2C9. In a reconstituted system containing cytochrome P450 2C9 and CPR the oxidation of 
substrates was compared with an increase in the amount of cytochrome b5. Using three 
different substrates, more than a 100% increase in product formation could be observed with 
a molar ratio of cytochrome b5 to cytochrome P450 2C9 of about 4. An increase in this ratio, 
to more than 4, resulted in a rapid decline in product formation. At ratios above 16, levels of 
product formation were almost completely depleted and the same as when no cytochrome b5 
was added [66]. During monooxygenase reactions, if a second electron is not supplied rapidly 
the substrate could dissociate from the P450 enzyme resulting in the release of superoxides, 
which can further dismutate to hydrogen peroxide [1]. During catalyses by cytochrome P450 
2C9, hydrogen peroxide formation was also significantly decreased when cytochrome b5 was 
present. A maximum decrease was observed at ratios where maximum product formation was 
observed. These findings suggested that not only did cytochrome b5 affect the catalyses of 
the P450 enzyme but that the amount of cytochrome b5 present also plays a vital role [66]. 
 2.6.6.3 Cytochromes P450 3A4 and 3A5 
These two P450 enzymes comprise around 50% of all cytochrome P450 enzymes within the 
liver [67]. Both of the enzymes are capable of metabolising testosterone and are highly 
depended on both CPR and cytochrome b5 for optimum activity [52]. Recently, Lee and 
Goldstein [68] did a comparative study between these two enzymes in the metabolism of 
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testosterone. They found that for the activity of the P450 enzymes was highly dependent on 
the amount of CPR present. For both enzymes, the metabolism of testosterone increased as 
the ratio P450 enzyme to CPR increased. This observation had a similar pattern for 
cytochrome P450 3A4/5. The activity increased to a ratio of about four to eight, while at 
higher ratios the activity gradually decreased. For all these experiments, cytochrome b5 was 
kept constant. To determine whether the amount of cytochrome b5 had an effect on the 
activity, the concentration was increased at the calculated optimum ratio of P450 to CPR. The 
authors reported that as the amount of cytochrome b5 was increased, so did the activity. This 
increase was up to a certain amount, where after the activity gradually declined. For both 
enzymes the highest activity was observed for a cytochrome b5 at the same molar amount 
(P450:b5:CPR 1:16:8 and 1:16:4 for 3A4 and 3A5 respectively). Their study showed that the 
activity of these enzymes are both influenced by cytochrome b5 [68]. 
2.7 Summary 
Cytochrome b5 is a protein that has been discovered a number of decades ago and has been 
shown to be involved in a number of reactions. It has also been shown that it plays a pivotal 
role during steroidogenesis by influencing the activity of at least two enzymes during steroid 
production. The postulated mechanisms of action for cytochrome b5 show the complexity of 
interactions between this protein and cytochromes P450 and more studies are needed to 
understand these hypotheses. In order to complete this study, cytochrome b5 was isolated 
from ovine liver microsomes. The reason for this was that the commercially available form of 
the protein is relatively expensive and large quantities were needed. The subsequent chapter 
discusses how the membrane bound protein was purified.  
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Chapter 3 
3. Isolation of Cytochrome b5 from ovine liver microsomes 
3.1 Introduction 
Cytochrome b5 is commercially available at certain chemical reagent suppliers. The 
recombinant form of the protein is, however, relatively expensive and supplied in µg amounts 
only. For this study, considerable amounts of cytochrome b5 were needed and due to the cost 
of commercial cytochrome b5 the protein had to be isolated from animal tissue.  
Cytochrome b5 was previously isolated from animal tissue [4] including ovine liver 
microsomes [3]. The hemoprotein exists as two forms, namely a soluble form, found 
primarily in the blood, and as a membrane bound form found in organs such as the liver and 
testes [9]. These two forms differ from one another in structure. The soluble form of the 
protein lacks the membrane anchoring region and has a reported molecular weight of ca. 11 
kDa [3], while the membrane bound form contains the membrane binding region and has a 
reported molecular weight of 15.2 kDa, excluding the heme group [6]. Storbeck et al. [6]  
reported that cytochrome b5, isolated from animal tissue, was able to form multimeric 
complexes and that the intact cytochrome b5 not only exists in vivo as a 16 kDa monomer, 
but also as homomeric complexes. 
In order to further investigate these findings, cytochrome b5 had to be isolated from ovine 
liver microsomes. In this chapter the purification of cytochrome b5 from ovine liver is 
described. This includes the preparation of liver microsomes and subsequent solubilisation of 
membranes. Cytochrome b5 was purified using three DEAE chromatography steps which 
were monitored by spectral analyses for the presence of cytochrome b5. The purified protein 
was subsequently subjected to SDS-PAGE and Western blot analyses, using antibodies 
previously raised in rabbits against cytochrome b5, to assess purity. Finally, cytochrome b5 
was subjected to ESI-MS for accurate weight estimation of the protein.  
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3.2 Experimental Procedures 
3.2.1 Preparation of ovine liver microsomes 
Ovine liver was collected from freshly slaughtered sheep from a local abattoir and liver 
microsomes were prepared as described by Yang and Cerderbaum. [4]. All experiments were 
performed at 4°C. The liver was washed with a 1.15% (m/v) KCl solution where after all 
connective tissue and excess fat was removed. The organ was cut into small pieces and 
placed in cold 10 mM TRIS-HCl buffer, pH 7.4, containing 1.0 mM EDTA and 0.25 M 
sucrose. The preparation was subsequently homogenised in a Waring blender at low speed, 
followed by homogenisation with a dounce homogeniser. This homogenate was centrifuged 
for 10 minutes at 500 × g where after the resultant supernatant was centrifuged again for 16 
minutes at 11 000 × g and the post mitochondrial fraction was collected. To prepare the 
microsomes, a 50% (m/v) polyethylene glycol 8000 (PEG) solution was added to the post 
mitochondrial fraction to a final PEG concentration of 8.5% (m/v) while stirring slowly. This 
mixture was stirred for an additional 10 minutes and centrifuged for 20 minutes at 13 000 × g 
to pellet the microsomes. The pellet was resuspended in 10 mM TRIS-HCl buffer, pH 7.4, 
containing 1.0 mM EDTA and 150 mM KCl using a dounce homogeniser. Again, PEG was 
added to this suspension to a final concentration of 8.5% (m/v) and stirred for 10 minutes. 
The suspension was centrifuged for 20 minutes at 13 000 x g. This procedure was repeated 4 
times and the final pellet was suspended in 10 mM TRIS-HCl buffer, pH 7.4, containing 1.0 
mM EDTA and 0.25 M sucrose. An aliquot was removed and the rest of the microsomal 
preparation was stored at −80°C until further use. 
 3.2.2 Determination of protein content 
The aliquot of prepared microsomes were thawed on ice and the total protein content was 
determined using a bicinchoninic acid (BCA) method. The method was followed as described 
according to the manufacturer’s instructions, using a dilution series of bovine serum albumin 
(BSA) as protein standard with concentrations ranging from 0.4 mg.mL-1 to 2.0 mg.mL-1 
[69]. 
 3.2.3 Solubilisation of microsomal membranes 
 Prior to chromatographic separation, the microsomes were solubilised using Triton X-100 as 
described by Yang and Cederbaum [4]. In brief, the protein concentration of the microsomes 
Stellenbosch University  http://scholar.sun.ac.za
26 
 
was determined using a BCA protein determination kit as described in section 3.2.2. The 
microsomes were then diluted to a concentration of ~8 mg protein/mL with 0.1 M TRIS-
acetate buffer, pH 8.1, containing 1 mM EDTA. A 10% (v/v) stock solution of Triton X-100 
was added to a final Triton X-100 concentration of 2% (v/v) and the resulting solution was 
allowed to stir at 4°C. After 60 minutes, PEG was added to the suspension to a final 
concentration of 8.5% (m/v) and stirred for an additional 30 minutes and subsequently 
centrifuged for 25 minutes at 13 000 × g. The resulting yellowish supernatant contained all 
previously membrane bound proteins, including cytochrome b5. 
3.2.4 Determination of cytochrome b5 content in ovine liver microsomes 
The concentration of cytochrome b5 within the prepared microsomes was determined 
spectrophotometrically  using a Beckman DU 650 spectrophotometer [27]. The solubilised 
microsomes were diluted 10-fold using phosphate buffered saline (PBS) and 1 mL of the 
diluted sample was placed in each cuvette inside the cell compartment. A baseline is recorded 
between 600 and 350 nm, to compensate for the difference in light absorbance between the 
sample cuvette and the reference cuvette. Once this baseline was established, cytochrome b5 
in the sample cuvette was reduced by the addition of NADH and a cytochrome b5 reduced 
difference spectrum recorded between 600 and 350 nm. The concentration of cytochrome b5 
was calculated from the reduced difference spectra using a molar extinction coefficient (ε) of 
185 mM-1.cm-1 and the absorbance change at 426 nm minus the absorbance at 409 nm.  
  3.2.5 Ion exchange column chromatography of solubilised microsomes 
Cytochrome b5 has a reported iso-electric point of ~4.4 [70]. Working at a physiological pH 
would thus mean the protein would carry a net negative charge. For purification of 
cytochrome b5, a suitable matrix bearing a positive charge was therefore used for the 
isolation of the protein of interest.  
Cytochrome b5 was isolated using a three step chromatographic procedure [71]. All 
chromatographic procedures were carried out at 4°C. The solubilised microsomes were 
thawed overnight at 4°C and applied to a DEAE-cellulose column (3.2 × 20 cm) equilibrated 
with 80 mM TRIS-acetate, pH 8.1, containing 1 mM EDTA and 2% Triton X-100 
(equilibration buffer A). After sample application, all unbound proteins were washed from 
the column with at least three bed volumes of equilibration buffer A. Cytochrome b5-
reductase was subsequently eluted with equilibration buffer A. The column was conditioned 
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with a linear gradient of NaSCN (0 – 50 mM), in elution buffer A, over three column 
volumes followed by the elution of cytochrome b5 with 90 mM NaSCN in elution buffer A. 
From the collected fraction, a 1 mL aliquot was stored at −20°C and the remainder 
subsequently dialysed overnight against 10 sample volumes of 10 mM TRIS-acetate buffer, 
pH 8.1 using a Spectra/Por® Dialysis Membrane. 
After dialyses, the dialysate was applied to a second DEAE column (2 × 20 cm) previously 
equilibrated with elution buffer A, containing 0.05% deoxycholic acid (equilibration buffer 
B). After sample application, the column was washed with 3 bed volumes of equilibration 
buffer B followed by a linear gradient from 0 – 50 mM NaSCN in the same buffer over three 
column volumes. The cytochrome b5 was eluted with a linear gradient from 50 – 90 mM 
NaSCN over five column volumes. Again an aliquot was taken, stored at −20°C and the 
eluted protein was dialysed in the same manner as mention before against 10 mM TRIS-
acetate, 0.1 mM EDTA, pH 8.1 (equilibration buffer C). 
To concentrate and remove the detergent from the dialysate, the cytochrome b5 preparation 
was loaded on a third, smaller, DEAE column (1 × 5 cm) equilibrated with the equilibration 
buffer C. The bound protein was then washed with at least 2.5 L of equilibration buffer C, 
whereafter the cytochrome was eluted with equilibration buffer C, containing 0.25 M NaSCN 
and 0.25% deoxycholic acid. Another aliquot was taken from the eluate before it was 
subjected to extensive dialyses against equilibration buffer C.  
 3.2.6 Determination of total protein content in purified fractions 
Total protein content of all collected fractions was determined using the BCA method 
previously described in section 3.2.2. 
 3.2.7 Determination of cytochrome b5 content 
Cytochrome b5 content within each of the three eluates was determined 
spectrophotometrically by the method described by Estabrook and Werringloer [27]. An 
appropriate dilution of the cytochrome b5 fractions was made using PBS buffer and an 
absolute spectrum of cytochrome b5 was recorded between 600 and 380 nm, using PBS 
buffer as a reference. The cytochrome b5 was subsequently reduced in the sample cuvette by 
the addition of sodium-dithionite. The reduced cytochrome b5 spectrum was recorded 
between 600 and 380 nm and the concentration of cytochrome b5 was determined by 
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applying a molar coefficient of 100 000 M-1cm-1 using the difference in absorbance at 424 nm 
between the reduced and the oxidised spectra.  
 3.2.8 SDS-PAGE analyses of cytochrome b5 
All purified fractions and solubilised microsomes were subjected to sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) analyses according to the method of 
Laemmli [72]. 
3.2.8.1 Preparation of separating gel and stacking gel  
To prepare the separating gel, 6.71 mL TRIS-HCl buffer, (0.56 M) pH 8.8, was mixed with 
100 µL 10% SDS, 5 µL N,N,N,N-tetramethylenediamine (TEMED) and 3.14 mL 
acrylamide/bisacrylamide (40% stock) solution. The polymerisation reaction was initiated by 
the addition of a freshly prepared 10% (m/v) ammonium persulfate, 50 µL. The mixture was 
poured, within a minute of initiation, between two glass plates spaced 1.5 mm apart. Time 
allowed for polymerisation was 45 minutes. For the stacking gel, 4.47 mL TRIS-HCl buffer, 
(0.14 M) pH 6.8,  was mixed with 50 µL 10% SDS, 5 µL TEMED and 0.5 mL 
acrylamide/bisacrylamide (40% stock) solution. The polymerisation reaction was initiated by 
the addition of 25 µL 10% ammonium persulfate. This solution was immediately poured on 
top of the separating gel and a 10-well comb was carefully inserted. After 30 minutes the 
glass plates were wrapped in moist tissue paper and the gel was stored overnight at 4°C. 
 3.2.8.2 Sample preparation for SDS-PAGE analyses 
In order for the separation of the proteins according to their molecular mass it needs to be 
treated with SDS, to not only denature proteins but also yield a same charge-to-mass ratio for 
all proteins present, and β-mercaptoethanol to break all disulfide bonds. Samples were 
denatured by incubating with equal volume Laemmli sample buffer® (67.5 mM TRIS-HCl 
buffer, pH 6.8, 2% SDS, 10% glycerine and 5% β-mercaptoethanol) at 90°C for 10 minutes, 
whereafter it was kept at 4°C until further use. 
 3.2.8.3 Gel electrophoresis of cytochrome b5 
 The proteins (2 – 10 µg) were loaded and separated using a BioRad MINI Protean system. 
The tank and inner chamber were filled with 25 mM TRIS-HCl buffer (pH 8.3), containing 
0.25 M glycine and 0.1% SDS. Separating conditions were 200 V for 60 minutes at 4°C. 
After protein separation, the gel was stained using a Coomassie Brilliant Blue R-250 staining 
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solution (3 mM Coomassie R-250, in 10% acetic acid and 45% methanol) for 60 minutes 
where after it was placed in destain solution 1 (50% (v/v) methanol, 10% (v/v) acetic acid) 
overnight. Rehydration of the gel was accomplished by placing it in destain solution 2 (20% 
(v/v) methanol, 7% (v/v) acetic acid). 
 3.2.9 Immunoblotting of cytochrome b5 
3.2.9.1 Western blot analyses of cytochrome b5 using anti-cytochrome b5 
immunoglobulins 
A Western blot analysis was also performed on separated proteins, after SDS-PAGE. The 
proteins were transferred to nitrocellulose membrane (BioTraceTM NT – Life Sciences) using 
a wet transfer system (transfer buffer: TRIS, (0.05 M), pH 8.3, 0.2 M Glycine and 20% (v/v) 
MeOH). A BioRad transfer system was used and the proteins were transferred at 110 volt for 
90 minutes at 4°C. The efficiency of the transfer was confirmed by the presence of the 
KaleidoScope rainbow marker used, as it could be visualised on the membrane without any 
additives. The resulting membrane was blocked by allowing the membrane to soak in casein 
buffer (10 mM TRIS, pH 7.6, 0.15 M NaCl, 0.5% (m/v) casein) for 30 minutes at 37°C with 
gentle agitation. This was followed by incubating the blocked membrane in a rabbit-anti-
cytochrome b5 antibody solution (1: 1 000 in blocking buffer) at 37°C. After 60 minutes the 
antibody solution was decanted and the membrane was washed 3 × 5 minutes with PBS – 
Tween-20
 
(PBS containing 0.1% Tween-20). After the wash step, the membrane was 
incubated with a previously diluted solution of goat-anti-rabbit secondary antibody (1: 20 000 
in blocking buffer), conjugated to horseradish peroxidase (HRP) (Sigma-Aldrich, St. Louis, 
USA). After 60 minutes at 37°C the membrane was once again washed as described earlier.  
 3.2.9.2 Visualisation of immobilised protein 
The immobilised protein was subsequently visualised by chemiluminesence. This was 
accomplished by incubating the membrane in a substrate solution (Pierce ECL Western 
Blotting substrate), prepared as described by the manufacturer’s instructions, for 1 minute 
and images were developed on X-ray film (Super RX – Fuji Medical X-Ray Film) with a 
minimum of 30 seconds exposure time. 
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3.2.10 ESI-MS analyses of cytochrome b5 
A technique commonly used for the accurate mass determination of biomolecules such as 
proteins is electrospray ionisation mass spectrometry (ESI-MS). During this process, 
particles, after a separation step, are ionised by using one of a number of known ionisation 
steps known. After ionisation, the charged particles move through a detector which detects 
the mass-to-charge ratio, which in turn can be used to determine the mass of the particle [73]. 
Prior to ESI-MS analysis, the sample should be free of high ionic strength buffers, detergents, 
etc, as these substances could interfere with the ionisation process which could lead to false 
results [74].  
As we have isolated the membrane bound cytochrome b5 using Triton X-100 it was 
necessary to determine the quantity within the final solution. The remainder of the 
detergent was removed using a Pierce® Detergent Removal Spin Column according to the 
procedure described by the manufacturer. In brief: after centrifugal removal of the storage 
solution, the column was washed/equilibrated using 400 µL PBS. The PBS was added on top 
of the column and the column was centrifuged 1500 × g for 1 minute. This step was repeated 
3 times before 100 µL of protein solution was applied slowly to the column, incubated for 2 
minutes at ambient temperature and the protein solution centrifuged for 2 minutes at 1500 × 
g. The protein solution obtained was immediately collected by placing in a 200 µL glass vial 
insert and sealed for ESI-MS analyses. The amount of detergent within the final dialysed 
fraction was determined spectrophotometrically. This was accomplished by using a standard 
curve created from a dilution series of detergent and the absorbance spectra from 260 to 300 
nm was measured (Cary Beckman DU 650). The fourth derivative spectra were calculated 
and plotted using the accompanied software (Cary Beckman UV-100 software). A standard 
curve was set up using a dilution of Triton X-100 (0.05% − 0.01%) in 1 M KOH. To 
determine the amount of Triton X-100 left in the dialysate, the cytochrome b5 sample was 
diluted 10-fold in 1 M KOH as the pH of this preparation is above 12 and all tyrosine 
residues are fully dissociated and would have an insignificant influence on the absorbance 
[75]. 
The accurate mass of desalted detergent free cytochrome b5 was determined with the use of 
ESI-MS. The protein solution was delivered to a Waters Synapt G2 instrument using a 
Waters Acquity UPLC® delivering a solvent gradient from 0.1% formic acid to 100% 
acetonitrile, at 200 µL/min, without the use of a column. The sample was introduced through 
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a conventional electronspray probe with a capillary voltage of 3.0 kV and a cone voltage of 
20 V. Data were collected in the positive mode by scanning over an m/z range of 200-3000. 
3.3 Results  
3.3.1 Total protein content in prepared microsomes 
Cytochrome b5 was prepared from fresh ovine liver microsomes using the PEG fractionation 
method. A summary of the purification results is given in Table 3.1.  
Table 3.1: Total protein content within the solubilised microsomal fraction. 
Fraction Mass of ovine liver (g) 
Total 
Volume 
(mL) 
[Protein] 
(mg/ml) 
Total 
Protein 
(g) 
Cytochrome b5  
content in 
microsomes (mM) 
Total 
Cytochrome b5 
(µmol) 
Triton X-100 
filtrate 800 550 5.91 3.25 1.77 0.97 
 
3.3.2 Determination of cytochrome b5 content in ovine liver microsomes 
Cytochrome b5 can be readily reduced using sodium dithionite in the absence of its redox 
partner cytochrome b5 reductase. In microsomes there are, however, other cytochrome P450 
enzymes present which can also be reduced and absorb in the Soret region. The appropriate 
reducing agent for cytochrome b5 would therefore be NADH. NADH reduces cytochrome b5 
reductase, still present in microsomes, which in turn specifically reduces cytochrome b5. A 
difference spectrum of cytochrome b5 (figure 3.1), with an absorption maximum at 426 nm, 
was used to determine the molar concentration of cytochrome b5 in the microsomal 
preparation. Using a molar extinction coefficient of 185 mM-1.cm-1 the cytochrome b5 was 
calculated to be 1.768 mM in the liver microsomal preparation (Tables 3.1 and 3.2). 
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Figure 3.1: Difference spectrum between oxidised and reduced cytochrome b5. The 
difference in absorbance at 426 nm and 409 nm was used for determining the 
cytochrome b5 concentration. NADH (2 mM) was used as reducing agent. 
3.3.3 Purification of cytochrome b5 using ion exchange chromatography  
Cytochrome b5 was purified chromatographically at 4°C. After applying the microsomes to 
the DEAE cellulose resin cytochrome b5 was separated from its redox partner, cytochrome 
b5 reductase, which eluted as a yellow band using a high concentration of TRIS-HCl buffer. 
A linear gradient of sodium thiocyanide was used to elute all impurities before cytochrome 
b5 was eluted as a red band from the column. The eluate was assayed spectrophotometrically 
for cytochrome b5 activity (figure 3.2 A). For this assay procedure, cytochrome b5 was 
reduced with sodium dithionite and cytochrome b5 was identified by the shift in absorbance 
maxima from 412 nm to 424 nm in the absolute absorption spectra shown in figure 3.2. 
Furthermore, the reduced spectra also contained additional identification peaks between 550 
and 570 nm. Once the presence of cytochrome b5 was established the eluate was dialysed and 
the procedure was repeated using a smaller column. This additional chromatography steps 
was not only used for purifying cytochrome b5 from contaminating proteins but also used for 
concentrating the protein. Figure 3.2 (B and C) represents the aliquots taken from the second 
and final chromatographic steps.  
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 Figure 3.2: Oxidised (blue line) and reduced (red line) spectra of different fractions during 
cytochrome b5 purification. Fraction from each column; 3.2 × 20 cm (A), 2.0 × 
20 cm (B) and 1.0 × 50 (C) cm, was reduced using a few grains of granular 
sodium dithionite. The shift in maximum absorbance from 412 to 424 nm 
confirmed the presence of cytochrome b5. 
C 
B 
A 
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 3.3.4 Determining total protein and cytochrome b5 content of purified fractions 
The total protein content was determined in each of the fractions using the BCA method with 
lysozyme as a standard. The cytochrome b5 content in each fraction was determined 
spectrophotometrically using the difference in absorbance of the reduced and the oxidised 
spectra at 424 nm and a molar coefficient of 100 000 M-1cm-1 to calculate the cytochrome b5 
concentration (figure 3.2). The results for total protein and cytochrome b5 concentrations are 
shown in Table 3.2. This table also contains a detailed set of purification data which were 
collected throughout the cytochrome b5 isolation procedure. 
Table 3.2: Purification table for cytochrome b5 isolated from ovine liver microsomes. 
Fraction  
Total 
Volume 
(mL) 
[Protein] 
(mg/ml) 
Cytochrome 
b5  (µM) 
Total 
Cytochrome 
b5 (µmol) 
Specific 
Activity 
(µmol/mg) 
Fold 
Purification 
Yield  
(%) 
Triton X-100 filtrate 550 5.91 1.77 0.972 0.0003 1.0 100 
1st DEAE Eluate 150 0.96 5.92 0.888 0.006 20.7 91.4 
2nd DEAE Eluate 87 0.33 6.96 0.606 0.021 69.7 62.3 
3rd DEAE Eluate 13 1.16 41.2 0.535 0.035 118 55.1 
  
During this study cytochrome b5 was isolated from ovine liver more than once, using the 
same procedure as discussed previously. We found, through up-scaling about three times, that 
the fold purification (for the last step) remained the same, but a similar final yield with a 
marginally lower specific activity was achieved than the smaller scale purification. Thus it 
can be said, although the yield is the same the purification is at least 50% lower in the scaled-
up process. The results for the up-scaled purification are depicted in table 3.3. 
Table 3.3: Purification table for cytochrome b5 isolated from 1500 mL ovine liver 
microsomes. 
Fraction  
Total 
Volume 
(mL) 
[Protein] 
(mg/ml) 
Cytochrome 
b5 (µM) 
Total 
Cytochrome 
b5 (µmol) 
Specific 
Activity 
(µmol/mg) 
Fold 
Purification 
 
Yield  
(%) 
Triton X-100 filtrate 1500 4.19 1.78 2.68 0.0004 1.0 100 
1st DEAE Eluate 290 1.40 9.12 2.64 0.0065 15.3 98.8 
2nd DEAE Eluate 82 1.01 20.3 1.67 0.0201 47.2 62.2 
3rd DEAE Eluate 66 1.03 22.3 1.47 0.0216 50.8 55.0 
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3.3.5 Gel electrophoresis and Western blot analysis of cytochrome b5
The purity of cytochrome b5 in isolated fractions was analysed using gel electrophoresis. The 
SDS-PAGE revealed that a protein with a molecular
together with other high molecular weight proteins. The latter proteins had the same 
molecular weight as that of the protein with the most prominent
microsomes (ca. 60 kDa). A duplicate gel was further subjected to Western blot analys
using rabbit anti-cytochrome b5 IgG. These antibo
as well as the high molecular weight protein present in microsomes. These 
represent the monomer (16 kDa) and the tetramer, which can be seen at approximately 60 
kDa. Confirming previous finding
vitro [3].  
 
 
 
 
 
 
Figure 3.3: SDS-PAGE and Western blot analyses of purified cytochrome b5 fractions. For 
SDS-PAGE (A) and Western blot (B) lanes; 1: Kaleidoscope Molecular weight 
marker, 2: Solubilised microsomes (10 
chromatography step (10 
chromatography step (10 
chromatography step (10 
antibody and a 1:20 000 secondary antibody dilution was used
Furthermore, it is also of note that other complexes are visible on both the polyacrylamide gel 
and the Western blot. These complexes could possibly be regarded as dimers (30
trimers (45-48 kDa), pentamers (75
latter multimeric complexes are not as prominent as the monomer (16 kDa) and the tetramer 
(60-64 kDa) in the purified fractions, but more immi
A)             1             2            3             4              5          B)      1           2            3         
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 weight of ca.16 kDa could be observed, 
 band present in the 
dies recognised both the prominent
prominent
s of multimeric complex formation by cytoc
µg), 3: Cytochrome b5 from first column 
µg), 4: Cytochrome b5 from second column 
µg) and 5: Cytochrome b5 from third column 
µg). For the Western blot analyses a 1:1 000 primary 
. 
-80 kDa), hexamers (90-96 kDa), etc. In addition,
nent in the microsomal suspension.
  4              5
is 
 bands, 
 bands 
hrome b5 in 
-32 kDa), 
 the 
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Tetramer  
Dimer  
Monomer  
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the Western Blot the presence of a dimer can be observed. This dimer is not clearly visible on 
the polyacrylamide gel. This could be as a result of sensitivities between the techniques. 
Figure 3.3 shows the stained gel together with the accompanying immunoblot developed on 
an X-ray film. 
3.3.6 Determination of Triton-X100 in dialysed fraction 
The purification of cytochrome b5 from animal tissue involves a number of steps which 
contains the detergent Triton X-100. These steps include the solubilisation of membranes, to 
release all membrane bound proteins, and the first two chromatographic steps [4]. Although 
the third and final chromatographic step involves the removal of all detergents through 
extensive washing, it was found that traces of detergents could still be detected. When 
determining the accurate mass of proteins in solution, using ESI-MS, it is crucial to have the 
sample free of any detergents as Loo et al. [74] reported that in many cases the ion signals 
from surfactants dominate and obscure protein mass spectra resulting in inaccurate mass 
determination. 
The absorbance spectra of each dilution were recorded and the fourth derivative spectra were 
calculated using the Cary Beckmann UV-100 software. The fourth derivative spectra for each 
was plotted (Figure 3.4) and the intensities of the spectral bands increased as the 
concentration increases. 
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Figure 3.4: The fourth derivative spectra of Triton X-100. The increase in the percentages of 
Triton is shown within the figure, ranging from 0.01% Triton X-100 to 0.05% in 
1 M KOH.  
The spectral data from figure 3.4 was used to construct a linear standard curve for the 
determination of Triton X-100. This was done by taking the difference at the fourth 
derivative wavelengths, the apex (X) at 276 nm and the valley (Y) at 280 nm. By plotting 
these against their relative Triton X-100 concentrations, a standard curve (figure 3.5) was 
obtained and used to determine the Triton X-100 content of the cytochrome b5 dialysate to be 
less than 0.004%. 
 
Figure 3.5: Standard curve obtained from the difference at wavelengths X and Y, 276 nm 
and 280 nm respectively. The amount of Triton X-100 present in protein solution 
was determined, from the standard curve, as 0.004%. 
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 3.3.7 Accurate mass determination of purified cytochrome b5 
Although it was found that there was less than 0.01% Triton present in the purified fraction 
after dialyses, this trace amount of detergent was enough to obscure the results obtained from 
ESI-MS. When cleaning the sample using a detergent removal column, it could be seen that 
ESI-MS could only detect a single heme containing protein and no other contaminants, such 
as detergents (figure 3.6). The molecular ions detected using mass spectrometry were not 
only that of the protein, but also the heme group. The heme can be seen on the ESI-MS 
spectrum with an accurate molecular mass of 616 Dalton. Deconvolution of the ESI-MS 
spectrum, figure 3.7, calculated the accurate monoisotopic mass of the detected protein to be 
15249 Da (theoretical Mr = 15330 Da), which correlated with the molecular weight 
previously reported by Lombard et al. [3]. According to the ESI-MS analysis the Mr of intact 
cytochrome b5 would therefore be 15865 Da, correlating with the 16 kDa band we observed 
for the monomeric cytochrome b5.  
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Figure 3.6: Multiprotonated ESI-MS positive-mode spectrum of the isolated cytochrome b5 fraction. A single protein which contains a 
protoporphyrin IX heme group with an accurate molecular weight of 616 Da was detected. 
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Figure 3.7: Deconvoluted spectrum of the multiprotonated spectrum of the cytochrome b5 preparation. The molecular mass of wild-type 
cytochrome b5, without heme, was determined to 15 249.0 Da.
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3.4 Conclusion 
Cytochrome b5 was previously isolated from ovine liver microsomes using the PEG 
fractionation method [3]. In this chapter, employing this method cytochrome b5 was 
successfully isolated from animal tissue.  
Spectral analyses showed that homogenisation steps did not affect the activity of the protein 
(figure 3.1) as cytochrome b5 could still be reduced by the cytochrome b5 reductase present 
in the microsomal preparation. Furthermore, solubilising the membranes using a mild 
detergent, Triton X-100, followed by the subsequent purification with multiple 
chromatographic steps showed cytochrome b5 was still capable of being reduced with sodium 
dithionite in the absence of its redox partner (figure 3.2). 
Purification data revealed cytochrome b5 was purified from ovine liver microsomes up to 120 
fold with less than 50% loss in the purification steps. During this study, cytochrome b5 was 
successfully purified a number of times. We also found that during up-scaling the 
purification, no significant difference in the yield could be noticed but a considerable 
decrease in the fold purification was observed. This can be seen by comparing tables 3.2 and 
3.3. From these data it could be concluded that when purifying more than 1 L of solubilised 
microsomes the third and final chromatographic step could be omitted, as this step did not 
lead to a significant increase in the fold purification but has the same loss (about 50%) in 
terms of yield as the “normal” scale. 
SDS-PAGE and Western blot analysis confirmed the presence of the full length protein, with 
most prominent bands visible at ~16 kDa and ~60 kDa. Other multimeric forms could also be 
observed, such as dimers, trimers and hexamers, but were not as prominent as the monomer 
and tetramer. Previously it has been reported that cytochrome b5, isolated from animal tissue, 
forms multimeric complexes [3][6]. These bands could also be detected using anti-
cytochrome b5 immunoglobulins, further confirming the presence of cytochrome b5 (figure 
3.3).  
Determining the amount of detergent left in the protein showed that there was less than 
0.01% Triton X-100 left after dialysis, this trace amount was enough to interfere with the MS 
signal. Using detergent removal columns, to totally remove the trace amount of detergent left, 
yielded ESI-MS spectrum (figure 3.6) with minimal background in the preparations. ESI-MS 
showed a single, heme containing protein with an accurate apo-protein mass of 15 249 Da 
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and the heme group to be 616 Da (figure 3.7). The molecular weight of cytochrome b5, 
determined by ESI-MS, correlated with the molecular mass of ovine apo-cytochrome b5 
determined from its amino acid sequence as 15330 Da. 
In Chapter 4 the investigation of the multimeric complexes of cytochrome b5 will be 
described. The appearance of multiple protein bands on SDS-PAGE, observed during 
purification of cytochrome b5, was investigated using different denaturing conditions as well 
as protein aggregation using a fluorescent dye. A number of techniques were employed to 
investigate the aggregation of the protein and factors which influence this aggregation.  
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Chapter 4 
4. Investigating aggregate formation of Cytochrome b5 
4.1 Introduction 
The molecular mass of ovine cytochrome b5 (without the heme) was previously determined 
by ESI-MS in our laboratory and was reported to be 15263 Da [3][6]. Also, in Chapter 3 we 
have reported the accurate molecular mass of isolated cytochrome b5 as 15249 Da, without 
the heme. The ESI-MS analyses from these studies showed that the cytochrome b5 
preparation contained a single monomeric heme containing protein. 
Previous studies in our laboratory have reported cytochrome b5 from animal tissue forms 
SDS stable multimeric complexes as visualised by SDS-PAGE. The cytochrome b5 that was 
isolated in this study (Chapter 3) showed similar behaviour. These aggregation states have, 
however, only been identified in vitro. Lombard et al. [3] reported that during separation of 
the full length cytochrome b5 protein by SDS gel electrophoresis, multiple protein bands 
could be observed. By removing the membrane anchoring domain through tryptic digestion, 
it was shown that the aggregation of the protein was totally abolished [3]. More recently, it 
was shown that aggregate formation by cytochrome b5 was not due to an artefact of the 
isolation procedure, but also occurred in vivo. Storbeck et al. [6] showed that heterologously 
expressed cytochrome b5 forms homomeric complexes in a COS-1 cell line. Furthermore, our 
studies supported the hypothesis that the membrane binding domain plays a pivotal role in the 
aggregation. 
In this chapter a broader investigation of the multimeric complex formation and aggregation 
of cytochrome b5 is described. As mentioned earlier, purified cytochrome b5 yields multiple 
protein bands when subjected to SDS-PAGE analyses and the most prominent protein bands 
are visible at molecular masses corresponding to 15 kDa and 60 kDa respectively. These 
bands were subsequently excised and identified using nano-LC-MS/MS. The aggregation of 
the protein was also investigated at different protein concentrations and ionic strengths. The 
role of the membrane binding of cytochrom b5 domain was also elucidated. 
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 4.2 Experimental Procedures 
4.2.1 SDS gel electrophoresis under extensive denaturing conditions 
Conventionally, sample preparation for denaturing gel electrophoresis involves the addition 
of Laemmli® [72] sample buffer to the protein sample in a 1:1 ratio followed by a heat 
treatment step. To analyse the aggregation of cytochrome b5, a number of different 
denaturing conditions were investigated prior to analyses on a 12.5% SDS-PAGE as 
described in section 3.2. Protein samples were prepared, after the addition of Laemmli® 
sample buffer, through: boiling for 10 minutes, boiling for 10 minutes in the presence of 8 M 
urea, incubation at 40°C for 30 minutes and incubation at 40°C for 20 minutes in the presence 
of 8 M urea.  
 4.2.2 Isolation of immunoglobulins specific for cytochrome b5 aggregates 
Western blot analyses of purified cytochrome b5, using polyclonal antibodies, yielded five 
prominent immuno-precipitation bands corresponding to the monomeric form of cytochrome 
b5 at 16 kDa, dimeric form at 32 kDa and a tetrameric form corresponding to a molecular 
mass of 60 kDa. Other forms, which were not identified but recognised by immunoglobulins, 
were the trimeric form at 48 kDa and a pentameric form at 80 kDa (Figure 3.3). We 
attempted the purification of the antibodies using the monomer and the most prominent 
aggregate, the tetramer, as immuno-affinity ligands to ascertain if the monomer presented the 
same antigenic determinants as the tetramer as obtaining antibodies specific for either form 
would be invaluable in the investigation of cytochrome b5 complex formation in vivo. A 
12.5% SDS gel was subsequently used to separate cytochrome b5 under the conditions 
previously described (section 3.2.8). The separated proteins were transferred to a 
nitrocellulose membrane (BioTraceTM NT – Life Sciences) where after it was stained with 
Ponceau S Solution to visualise the transferred proteins. Two membrane strips, containing the 
proteins bands with the most prominent signal, at 16 and 60 kDa respectively, were cut out 
and extensively washed with water prepared by reverse osmosis (RO-water) to remove all 
Ponceau S solution. After removal of staining solution, the strips were incubated for 30 
minutes in casein blocking buffer. The strip, corresponding to 60 kDa, was subsequently 
incubated for 90 minutes in primary antibody solution (1: 500). Immobilised 
immunoglobulins were removed by incubating the strip in 5 mL of a 0.2 M glycine, pH 2.5 
for 4 minutes followed by transfer to 0.5 mL 1 M TRIS-HCl buffer, pH 8.0, and the pH was 
Stellenbosch University  http://scholar.sun.ac.za
45 
 
adjusted to 7.0 using NaOH. This step was repeated 3 more times using the same primary 
antibody solution. After the third immunoglobulin isolation step, the same serum solution 
(used for the isolation of the 60 kDa antibody) was used and the procedure described above 
was repeated for the 16 kDa strip. These affinity purified immunoglobulins were used, 
undiluted, for Western blot analyses (as described in section 3.2.9) to assess if the antibodies 
isolated were specific for either the monomer or the aggregate [6]. The visualisation method 
for the western blot differed for the the method described in the previous section. For this 
NBT/BCIP solution was used for colour development (at least 2 minute exposure). 
4.2.3 SDS-PAGE of cytochrome b5 and excision from SDS gel 
Mass spectrometry based proteomics was performed to unambiguously identify the bands 
present on SDS polyacrylamide gel as cytochrome b5. Cytochrome b5 was subjected to SDS- 
PAGE analyses as previously described. The gel was stained using Coomassie stain for 45 
minutes and destained overnight. Further analyses, as described in this section, were 
performed by the Central Analytical Facility of the University of Stellenbosch. Bands, 
corresponding to 16 and 65 kDa respectively, were excised from the gel and cut into smaller 
squares, approximately 1 mm × 1 mm. Each band was transferred to a separate 1.5 mL 
Eppendorf, where it was first washed with 2 × 300 µL of deionised water followed by 
washing with a 50% (v/v) acetonitrile in water. After 10 minutes the acetonitrile mixture was 
replaced with 50 mM ammonium bicarbonate and incubated for 10 minutes. The acetonitrile 
and ammonium bicarbonate washing steps were repeated until all the Coomassie stain was 
completely removed, usually 3 – 4 wash steps. The final wash step was followed by 
incubating the gel squares in acetonitrile until a white discolouration occurred, the 
acetonitrile was removed and the gel was dried in a vacuum.  
4.2.4 Reduction, alkylation and trypsin digestion of intact protein  
Although sample preparation for the gel electrophoresis involves the reduction of disulfide 
bonds, it is necessary to treat the separated proteins with a reducing agent followed by the 
irreversible alkylation of the thiol groups preventing the formation of disulfide bonds. The 
dried gel squares were incubated for 60 minutes at 57°C with a reducing agent (10 mM DTT, 
100 µL) where after it was washed once as previously mentioned (section 4.2.3). The 
alkylation of the proteins was subsequently accomplished by incubating the gel squares with 
55 mM iodoacetamide (100 µL) for 60 minutes in the dark, followed by washing with a 50 
mM ammonium bicarbonate solution for 10 minutes followed by 50% (v/v) acetonitrile/water 
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for 20 minutes before drying under vacuum. Digestion of the proteins was accomplished by 
the addition of 200 ng of trypsin in solution and incubating for 17 hours at 37°C. The 
resulting peptides were isolated from the gel by separating the trypsin from the gel squares 
and extracting the peptides with 2 x 300 µl 70% (v/v) acetonitrile in 0.1% (v/v) formic acid in 
water for 30 minutes. 
 4.2.5 Removal of salts and other contaminants from extracted peptides 
To decrease the interference on MS by adducts the salts were removed from each sample. 
The solution containing the isolated peptides was subjected to a stage tip, containing C18 
matrix, to remove all salts. The C18 matrix was activated by washing with 300 µL methanol. 
The stage tip was equilibrated with 300 µL of 0.1% formic acid, where after the sample was 
applied. The C18 material was washed with 2 × 300 µL of H2O and the peptides were eluted 
with 2 × 300 µL 70% (v/v) acetonitrile in 0.1% (v/v) formic acid. Peptides were dried and 
stored at −20°C until analyses. 
 4.2.6 Nano-Liquid Chromatography of peptides 
Mass spectrometry was performed on a Thermo Scientific EASY-nLC II connected to a LTQ 
Orbitrap Velos MS (Thermo Scientific, Bremen, Germany) equipped with a nano-
electrospray source. Separation of the peptides was achieved chromatographically, using a 
two column chromatographic step on an EASY-Column (2 cm, ID 100 µm, C18, 5 µm particle 
size) pre-column followed by an EASY-Column (10 cm, ID 75 µm, C18, 3 µm particle size), 
at a flow rate of 300 nL/min. The peptides were dissolved in 20 µL 20% (v/v) acetonitrile 
containing 0.1% (v/v) formic acid and 10 µL was injected. The chromatographic conditions 
were as follows: Solvent A; H2O containing 0.1% (v/v) formic acid, Solvent B; 100 % (v/v) 
Acetonitrile containing 0.1% (v/v) formic acid and a gradient from 5−40% solvent B over 20 
minutes, 40−80% solvent B over 5 minutes and kept at 80% solvent B for a further 10 
minutes to complete the run. 
 4.2.6 MS/MS analyses of peptides 
The mass spectrometer was operated in data dependent mode. This allowed for automatic 
switching between the acquisition of the Orbitrap-MS and the LTQ-MS/MS. The former 
acquires the precursor ion spectra, with resolution R = 60 000. Further fragmentation took 
place in the linear ion-trap using an induced dissociation. Conditions for the mass 
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spectrometer were 1.5 kV, 200°C with no sheath and auxiliary gas flow and ion selection 
threshold of 500 counts for MS/MS. 
4.2.7 Investigation of cytochrome b5 aggregation using a fluorescent dye 
1-Anilinonaphthalene-8-sulfonic acid (ANS) is a fluorescent dye commonly used in the study 
of protein aggregation in solution. The molecule is an amphiphilic probe of which the 
fluorescence increases when it enters a hydrophobic environment. As it was previously 
reported that the membrane anchoring domain plays a vital role in the aggregation of the 
protein [6], we used ANS to investigate whether the aggregation could cause an increase in 
ANS fluorescence.  
 4.2.7.1 Effect of protein content on aggregation 
To study the effects on protein concentration, cytochrome b5 (100 µg; final volume 150 µL) 
a dilution series was prepared in a 96 well NUNCTM fluorescence plate with PBS as diluent. 
The loaded plate was covered and pre-incubated at 37°C and after 20 minutes, 1.11 µL of 6.5 
mM ANS (50 µM final concentration) was added to each well and the 96- plate was 
incubated at ambient temperature for another 15 minutes. This was considered sufficient time 
for the interactions to fully proceed, where after the fluorescence was measured using a 
Thermo Varioskan fluorescence detector equipped with Varioskan software. The excitation 
wavelength was set to 388 nm and each well was scanned for fluorescence emission over a 
wavelength range ranging from 420 to 600 nm. Cytochrome C, another heme containing 
protein, was used as a control protein for the experiment. Wells containing only the protein 
solution, without any fluorescent probe, were also included as negative controls. 
       4.2.7.2 The effect of ionic strength on cytochrome b5 aggregation 
A number of factors have been shown to have an effect on the aggregation state of protein 
complexes, including ionic strength. To study this effect on cytochrome b5 complex 
formation, cytochrome b5 (1.1 mg/mL) was diluted, using phosphate buffer having different 
molar concentrations ranging from 5 mM – 1 000 mM, to a final protein concentration of 0.1 
mg/mL. These dilutions were pre-incubated overnight at 4°C, where after it was transferred 
to a NUNCTM fluorescence plate (200 µL/well) and incubated at 37°C. After 20 minutes ANS 
was added, the mixture incubated for 15 minutes and the fluorescence measured as described 
in section 4.2.7.1. 
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 4.2.7.3 The effect of the membrane binding domain of cytochrome b5 on aggregation 
Previous studies in our laboratory showed that, when removing the membrane binding 
domain of cytochrome b5 through tryptic digestion, a protein with a single molecular mass of 
ca. 10 kDa, was observed [3]. This form of the protein was named truncated cytochrome b5. 
Truncated cytochrome b5 was prepared as described by Lombard et al. [3]. Briefly, 1 mg of 
cytochrome b5 was immobilised on a DEAE-cellulose column, dimensions 1 × 5 cm, 
equilibrated with 10 mM TRIS-Acetate buffer, pH 8.1 containing 25 mM CaCl2. After 
protein immobilisation, the column was washed with 20 mL equilibration buffer followed by 
the circulation of trypsin solution. Trypsin at 5000 units/mL was continuously circulated 
through the column at 4°C. After 16 hours, the column was extensively washed, 10 column 
volumes, with equilibration buffer to remove all traces of resulting peptides and trypsin 
before the truncated cytochrome b5 was eluted using a 10 mM TRIS-Acetate buffer, pH 8.1, 
250 mM Sodium Thiocyanate (NaSCN) containing 1 mM EDTA. The eluate was 
concentrated using a LABCONCO® CentriVap Concentrator followed by extensive dialysis 
against 10 mM TRIS-acetate buffer, pH 8.1 containing 1 mM EDTA. The total protein of the 
dialysate was determined using the BCA method described in section 3.2.2 and analysed 
through SDS- PAGE as described by section 3.2.8. 
The aggregation of the truncated form of the protein was analysed in the same manner as 
described earlier in section 4.2.7.1. Cytochrome b5 and truncated cytochrome b5 (100 µg) 
were diluted in series and incubated at 37°C for 20 minutes, where after ANS was added and 
the fluorescence was measured. 
4.3 Results 
4.3.1 SDS-PAGE under extensive denaturing conditions 
Evidence from ESI-MS spectra previously obtained (section 3.3.7) indicated that the purified 
fraction was a single heme containing protein. Conversely, the SDS polyacrylamide gel 
indicated that the purified fraction does not contain a single protein band at the expected 
molecular weight of 16 kDa, but rather multiple protein species, with the most prominent 
bands corresponding to molecular masses of 16 and 60 kDa. Although these multi-species 
were observed, only a single protein could be detected by ESI-MS analysis (Chapter 3) which 
led us to the following conclusions; that these species might be homomeric complexes of 
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cytochrome b5 and/or be a result of protein degradation or protein mixtures. The effect of 
different denaturing conditions was investigated and it was f
denaturing conditions the different aggregates persisted. As shown in Figure 4.1, no notable 
difference, either in lane profiles or in band intensities, could be observed regardless of the 
denaturing protocol followed. Furthermore
cysteine decarboxylase, was added
aggregated state (usually 75 kDa)
and using the traditional method
to completely denature the protein
 
 
 
 
 
 
 
 
 
Figure 4.1: SDS polyacrylamide gel containing cytochrome b5 with different denaturing 
conditions, after the addition of equal volume Leammli® Sample Buffer. Lane 1: 
BioRad Precision Plus Protein Standard, lane 2: 
phosphopantothenoyl
3: cytochrome b5 (12
incubated for 30 minutes
urea, boiled for 10 minutes
urea, incubated for 20
 4.3.2 Isolation of immunoglob
As shown on the immuno-blot, in Chapter 3 (Figure 3.3), antibodies raised against purified 
cytochrome b5 detected both the monomeric and 
immunoglobulins were purified using an immuno
of the immunoglobulins to their antigens and their subsequent removal from solution through 
Lanes:                 
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incubation in a 0.2 M glycine solution at an acidic pH. When reused for Western blotting 
purposes, the immunoglobulins isolated from the tetrameric cytochrome b5 only recognised 
the tetrameric form of the protein and not the 16 kDa monomer. In contrast the monomeric 
antibody recognised both the monomer and the tetramer as antigen. The latter yielded a more 
intense signal indicating that the immunoglobulin recognising cytochrome b5 monomers 
showed more affinity for the tetrameric form rather than the monomeric form (figure 4.2). 
 
 
 
 
 
 
 
Figure 4.2: Western blot using affinity purified immunoglobulins. Western blot was 
completed with sera dilutions for strips 1 and 2, 1: 1000, and undiluted affinity 
serum (strips 3 and 4). Secondary antibody (goat anti-rabbit conjugated to 
alkaline phosphatase) 1: 20 000. Strip 1: stained SDS gel with cytochrome b5 (7 
µg), strip 2 cytochrome b5 (7 µg) blotted with whole serum, strip 3: cytochrome 
b5 (7 µg) blotted with “stripped” serum, strip 4: cytochrome b5 (7 µg) blotted 
with tetramer immunoglobulins and strip 5: cytochrome b5 (7 µg) blotted with 
monomer immunoglobulins. 
 4.3.3 Identification of excised bands using nLC-MS/MS 
As both the 16 and 60 kDa bands were indicated to be cytochrome b5, through recognition by 
affinity purified immunoglobulins, we further investigated these bands using nLC-MS/MS. 
This process involved the identification of peptide amino acid sequences and comparing it 
against a library. Two bands, the monomer (16 kDa) and tetramer (60 kDa), from the SDS-
PAGE gel were excised and further analysed for the presence of cytochrome b5. The excised 
bands underwent proteolytic digestion, using trypsin, and the resulting peptides were further 
reduced and alkylated, where after it was separated using nano-liquid chromatography before 
ionisation. MS/MS analyses on the generated peptides confirmed that their amino acid 
sequences, when compared with library sequences, originated from cytochrome b5 as 
1          2         3         4          5
Monomer
Tetramer
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indicated by high scores and coverage (table 4.1).  
both bands detected with SDS-PAGE.
Table 4.1: Identification of excised bands with nLC
Molecular Weight 
on SDS Gel (kDa) 
Sequence Matched 
(Species) 
16 Cyt b5 from Bovine 
60 Cyt b5 from Ovine 
 4.3.4 Investigating aggregate formation 
 4.3.4.1 Effect of protein concentration on aggregation
The effect of protein concentration on the aggregation has been previously investigated by 
the Adriaanse [77]. It was found that the aggregation of cytochrome b5 could be manip
by the concentration. Through serial dilution of cytochrome b5, it was shown that the 
presence of the tetramer decreased while that of the monomer remained (figure 4.3). 
Analysing the densities of the most prominent protein bands, which represents t
trimer and tetramer, it was concluded that the aggregation was, indeed, concentration 
dependent. 
 
 
   
 
 
 
 
Figure 4.3: Previous studies [77]
aggregation of cytochrome b5.  
containing the molecular 
cytochrome b5 ranging from 22 µg to 0.13 µg. A graphical representation of the 
concentration dependence of cytochrome b5 aggregation as detected by SDS
PAGE is given in B
     A      1    2     3    4     5    6    7     8     9    10            B
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For the new studies, using the fluorescent dye ANS to study cytochrome b5, we included a 
number of controls, one of which was cytochrome C, a small heme containing protein, which 
is also involved in electron transfer reactions and has a similar molecular mass as that of 
cytochrome b5. ANS is commonly used for studying peptides and proteins which form 
complexes. When proteins or peptides aggregate, they form hydrophobic crevices. When the 
ANS is present it occupies these hydrophobic pockets and when excited it emits fluorescent 
light with maximum at 470 nm. The fluorescence detected is also directly proportional to the 
amount of aggregation present within the solution. 
As ANS’s fluorescence increases when embedded within a hydrophobic crevice, it was 
important to include cytochrome C as control because both cytochrome C and cytochrome b5 
contain heme groups which are located in a hydrophobic pocket. Thus, the only difference 
between these proteins is the fact that we found that cytochrome b5 forms SDS stable 
aggregates and cytochrome C does not. 
ANS fluorescence experiments confirmed that cytochrome b5 forms complexes or higher 
aggregates that is concentration dependent (figure 4.4). The increase of ANS fluorescence 
was significant when the ANS and the purified protein were present in the same environment. 
A serial dilution of cytochrome b5 caused a decrease in the fluorescence, while varying the 
cytochrome C concentration (figure 4.5) did not have any effect on the fluorescence. This 
suggested that cytochrome b5 forms aggregates in vitro and that the aggregation is dependent 
on the amount of protein present, with onset of aggregation at 0.95 µg/ml and 50% 
aggregation calculated at 1.56 µg/mL (figure 4.6). These observations correlated very well 
with our SDS-PAGE results from a previous study [77] (figure 4.3).  Recently our group has 
also shown that the in vivo aggregation state of cytochrome b5 was dependent on the amount 
of expressed protein, and this study also showed a definite decrease in fluorescence as the 
amount of protein decreased [6]. 
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Figure 4.4: Emission spectra of 50 µM ANS in the presence of different concentrations of 
purified full length cytochrome b5 in PBS.  
 
Figure 4.5: Emission spectra of 50 µM ANS in the presence of different concentrations of 
cytochrome C in PBS  
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Figure 4.6: ANS fluorescence at 470 nm as a function of protein concentration. The arrow 
indicates the onset of aggregation at 0.95 µg/mL. The protein concentration at 
50% aggregation was determined to be 1.56 µg/mL. The data points depicted are 
the mean ± standard error of two determinations. 
 4.3.4.2 Effect of ionic strength on protein aggregation 
Lombard et al. [3] previously reported that cytochrome b5’s aggregation/complex formation 
was affected by the ionic strength of the buffer. We investigated this by pre-incubating the 
same amount of protein in a phosphate buffer with an increase in ionic strength. For this, 100 
µg of cytochrome b5 was incubated in phosphate buffer, pH 7.2, ranging from 5 mM to 1000 
mM in concentration. It was confirmed that the ionic strength had an effect on the 
aggregation (figure 4.7). As the ionic strength increased, there was an increase in the 
fluorescence indicating increased cytochrome b5 aggregation. 
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Figure 4.7: Effect of ionic strength on cytochrome b5 aggregation. This was generated with a 
non-linear fit to three analyses repeats. 
 4.3.4.3 Effect of the membrane binding domain on aggregation 
More recently, studies by our group indicated that the membrane anchoring domain plays a 
vital role in the aggregation of cytochrome b5 [3][6]. We also investigated this with 
fluorescence using the truncated form of the protein. Truncated cytochrome b5 was prepared 
using the method described by Lombard [5]. This involved the overnight exposure of full-
length cytochrome b5 to trypsin. After 16 hours of digestion, the truncated form of the 
protein eluted from the column as a distinct sharp peak. This peak was collected, dialysed, 
concentrated and the protein concentration was determined to be ca. 1.6 mg/mL.  
The purity of the fraction was determined with SDS gel electrophoresis (figure 4.8 A) and it 
showed that the truncated form of the protein was present (11 kDa) with a slight 
contamination of trypsin (faint band at 25 kDa). In contrast to the full length cytochrome b5, 
no increase in ANS fluorescence was detected for the truncated form of the protein upon an 
increase in protein concentration (figure 4.8 B). This finding confirmed that the truncated 
form did not form aggregates and that the membrane binding domain plays a pivotal role in 
cytochrome b5 complex formation. 
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 Figure 4.8: SDS polyacrylamide gel and ANS fluorescence for truncated cytochrome b5 A) 
SDS gel containing in lane 1: BioRad Precision Plus Protein Standard, lane 2: full 
length cytochrome b5 (5 µg) and lane 3: truncated cytochrome b5 (5 µg). B) 
Serial dilution of truncated cytochrome b5 from 100 µg/mL 
 4.4 Conclusion     
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profile. This finding suggested that the multimeric forms of cytochrome b5 are very stable 
complexes, as a control protein (human phosphopantothenoyl cysteine decarboxylase) fully 
dissociated to its monomeric state using the conventional denaturing conditions and 
Laemmli® sample buffer. 
During Western blot analyses, antibodies raised against cytochrome b5 predominantly 
recognised both the monomeric and tetrameric form of the protein. Isolating the antibodies 
for these forms and reusing it for Western blot analyses showed that the immunoglobulins 
isolated against the tetramer specifically only recognised that form whilst the 
immunoglobulins recognising monomeric cytochrome b5 cross-reacted with the tetrameric 
cytochrome b5 (figure 4.2). This result indicated that the conformation of the cytochrome b5 
changed significantly upon aggregation and that the aggregated form was immunologically 
distinct from the monomeric form. 
Furthermore, after separation of cytochrome b5 using SDS-PAGE, the monomer and tetramer 
was excised from the stained gel. These excised bands were digested by trypsin and the 
resulting peptide fragments identified using MS/MS. The results revealed that both excised 
bands contained peptides with sequences corresponding to that of cytochrome b5 (table 4.1). 
A fluorescent dye ANS was used to investigate the concentration and ionic strength 
dependence aggregate formation of cytochrome b5. Heme containing proteins contain a 
hydrophobic pocket in which the heme is embedded, thus as a control a second heme 
containing protein (cytochrome C) was used. Cytochrome C showed no aggregation tendency 
as ANS fluorescence did not significantly increase with increase in protein concentration 
(figure 4.5), while an increase in cytochrome b5 concentration led to an increase in ANS 
fluorescence (figure 4.4). The oligomeric complex formation of cytochrome b5 was thus 
confirmed being both protein concentration and ionic strength dependent (figures 4.6 and 
4.7).  
Previous studies on cytochrome b5 showed that the membrane anchoring domain plays a 
crucial role in the aggregation of cytochrome b5[3][6]. By tryptic removal of this domain, the 
aggregation state of cytochrome b5 was abolished as indicated by the absence of fluorescence 
by the truncated form of the protein (figure 4.8).  
The results presented in this chapter confirm earlier observations that cytochrome b5 forms 
stable oligomeric aggregates. The stability and specific dominance of the tetrameric 
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complexes strongly indicated that a specific region or regions in the cytochrome b5 molecule 
were responsible for the formation of the tetrameric form of the protein observed in vitro. In 
Chapter 5 experiments are described to investigate a peptide sequence, identified by our 
group, as being responsible for aggregation. For this study, synthetic peptides were used to 
study secondary structure as well as interaction between the peptides and purified cytochrome 
b5. An enzyme linked affinity assay was developed to elucidate the interaction between 
purified cytochrome b5 and a synthetic peptide to gain insight into the aggregate formation of 
cytochrome b5. 
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Chapter 5 
An investigation of the mechanism of cytochrome b5 aggregation  
5.1  Introduction 
During a study on the metabolism of progesterone in sheep adrenal microsomes,  Swart et al. 
[78] also investigated the influence of cytochrome b5 on progesterone metabolism. Purified 
ovine cytochrome b5 and anti-cytochrome b5 serum were used to alter the cytochrome b5 
levels in the ovine adrenal microsomes [78]. In these studies, cytochrome b5 addition had an 
apparent inhibitory effect on P450c17, while P450c21-activity appeared to be unaffected by 
changes in cytochrome b5 levels. No significant lyase activity towards progesterone could be 
detected in any of the experiments. These results were in contrast with results previously 
reported for guinea pig microsomes, where both P450c17 and P450c21 were stimulated by 
the addition of cytochrome b5 [79]. The investigators hypothesized that the selective 
influence of cytochrome b5 on sheep adrenal P450c17, shown in the study by Swart et al. 
[79], could explain the increase in cortisol to corticosterone ratios which occurred in certain 
animals upon hormonal stimulation. They concluded that this increase could only be due to 
an increased P450c17-activity, as the P450c21-activity was unaltered by changes in the 
cytochrome b5 levels in ovine adrenal microsomes. This observation also ruled out the 
possibility that cytochrome b5 interferes with the action of cytochrome P450 reductase. 
The properties of ovine cytochrome b5 were subsequently investigated in our group, using  
SDS-PAGE, electrospray mass spectrometry and UV-VIS-spectroscopy to ascertain if the 
ovine derived enzyme differed significantly from the cytochrome b5 already characterised 
from other species [5]. The spectra of the purified ovine cytochrome b5 in the Soret region 
were identical to the spectra previously obtained for cytochrome b5 from other species. On 
SDS-PAGE the full-length protein exhibited a major protein band corresponding to a 
molecular mass of ±16 kDa, which represented the monomeric form of cytochrome b5 in 
accordance with previously published data [12]. Several bands corresponding to multimeric 
forms of the protein were, however, also observed. ESI-MS analyses of the same cytochrome 
b5 preparation, previously analysed by SDS-PAGE, indicated the presence of a single protein 
with a molecular mass of 15260 Da, corresponding to the molecular mass of apo-cytochrome 
b5. These findings indicated that the SDS-PAGE conditions, normally used for the resolution 
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of protein complexes, did not fully dissociate the cytochrome b5 aggregates. A truncated 
cytochrome b5, prepared by tryptic digestion, showed no aggregation and yielded only a 
single band on SDS-PAGE corresponding to a molecular mass of ±10 kDa. The aggregation 
of cytochrome b5 was further confirmed by high performance gel permeation 
chromatography (HP-GPC). HP-GPC analyses of the purified protein, under conditions of 
low ionic strength (10 mM TRIS, 0.1 mM EDTA, pH 8.15), yielded two peaks with both 
fractions exhibiting a typical cytochrome b5 absorption spectrum. These two fractions were 
collected and immediately rechromatographed under the same conditions. Each sample 
produced a single peak. When the same two fractions were incubated for 24 hours before they 
were rechromatographed, the higher molecular mass component dissociated into two 
fractions while the lower molecular mass fraction remained a single peak. Under conditions 
of higher ionic strength, only the higher molecular mass aggregated form of cytochrome b5 
was observed in HP-GPC analyses [3]. The induction of higher molecular mass aggregates of 
cytochrome b5 by high salt or protein concentrations agreed with data previously published 
by Calabro and Katz [80]. Western blot analyses of adrenal and testicular tissue from 
different species showed that the cytochrome b5 was present in an aggregated 64 kDa form 
with little or no monomer being detected. From these studies we concluded that, apart from 
the aggregation to form specific 64 kDa tetramers, the ovine cytochrome b5 exhibited no 
anomalous structural characteristics.  
As discussed earlier, recent studies in our group revealed that the linker and the membrane 
anchoring domains play a pivotal role in the oligomerisation of cytochrome b5. Using 
fluorescence resonance energy transfer (FRET) studies Storbeck et al. [6] showed that 
cytochrome b5 formed homomeric complexes in COS-1 cells and that the linker domain 
plays a vital role in the formation of these complexes. In our studies, it was shown that in 
COS-1 cells expressing full-length cytochrome b5 complex formation could be observed 
using FRET. Also, when co-expressing full-length cytochrome b5 with P450c17, it was 
observed that the protein predictably augmented the lyase activity of P450c17. With the 
truncated form of the protein, FRET studies revealed that minimal fluorescence could be 
observed [6] confirming that removal of the membrane anchoring domain decreased 
aggregation of the protein considerably [3]. Furthermore, co-expressing the truncated form of 
cytochrome b5 with P450c17 also had a stimulatory effect on the lyase activity of the P450 
enzyme, although less than 50% conversion of the substrate was observed when compared to 
incubation with full length cytochrome b5 [6]. It was also shown that, without the globular N-
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terminus head domain, almost the same conversion of 17-OH-PREG to DHEA could be 
obtained as for the truncated form. For a form containing only the membrane anchoring 
region and the linker domain, the same observation was made. FRET also showed that the 
construct containing only the membrane anchoring domain and the linker also forms 
complexes in vivo [6].  
In this chapter a synthetic peptide, corresponding to the hinge domain, was used to 
investigate its association with purified cytochrome b5.  The synthetic peptides which were 
used were the following: a wild-type peptide (IITTIDSNSS) and a control peptide; 
(LLSSLKAVAV). Circular dichroism was used to determine whether this synthetic peptide, 
and its control, had any regular or irregular structure in solution. Also, a modified enzyme 
linked immunosorbant assay (mELISA) was developed for studying the association of the 
linker with the protein. The mELISA was used to establish if peptides were able to associate 
with purified protein, whether association was specific and if saturation could be obtained 
between the protein and a biotinylated-peptide. The biotinylated-peptides contained the same 
sequences but were conjugated, at the N-terminus, to biotin via an aminohexanoic acid linker.  
5.2  Circular Dichroism Spectroscopy 
Circular dichroism (CD) measures the difference between the absorption of left– and right 
circular polarised light which arise due to structural asymmetry of molecules. Circular 
polarised light are interconvertible with plane-polarised light. The latter beam consists of 
right– and left circularly polarised beams of equal intensities, where as the former has two 
orthogonal plane-polarised beams which are 90 degrees out of phase. The absorbance for the 
left-circular polarised light can be given by the equation;  
Al = log10 (I0l/Il) = εlCl 
where I0l and Il are the intensities of left-circular polarised incident on the sample and 
travelling distance l through a medium which contains a molar concentration (C) of a chiral 
solute. A corresponding equation can be used for the right-circular polarised light [81].  
Modern instruments, which measure CD, using a modulation technique, generally measure a 
change in absorbance which is very small. Thus, for logical reasons many use ∆ε to report 
CD data. However, this is not the only measure of CD and numbers of alternatives are used 
especially in the biochemical literature. The first method of measuring CD took advantage of 
the fact that, when passed through a circular dichroic medium, the differential absorption of 
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the two circular components converts the plane-polarised light into elliptically polarised light. 
When the electric vectors of these two components are in the same direction, the sum of their 
magnitudes yields the semi-major axes of the ellipse, where as when they are in the opposite 
direction, the difference yields the semi-minor axes. Ellipticity (θ) can be characterised using 
these axis by taking the ratio of the semiminor and semimajor. This ellipticity is directly 
proportional to CD and is widely used in literature. Moreover, CD spectra in biochemical 
literature are often reports the data in terms of molar ellipticity ([θ]). This conversion, from 
ellipticity to molar ellipticity, is relatively simple. Despite the scale for presenting CD data it 
is also common practise to use different forms of ellipticities for different regions of the 
wavelength spectrum. When working in the near-UV region one often reports the data in 
terms of protein molarity while when working in the far-UV region the data is reported in 
terms of mean residue concentration; the latter is commonly used for polypeptides and 
proteins. The mean residue is calculated as the product of the molar concentration and the 
number of amino acids of the protein. 
5.3 Experimental Procedures 
5.3.1 Circular Dichroism analysis of peptides 
5.3.1.1 Accurate weighing of wild-type –and control peptides 
Ca. 1.5 mg peptide was measured in a clean, pyrolised glass vial and dissolved in ultra pure 
water (500 µL). The suspension was lyophilised overnight where after it was placed in a 
desiccator, containing a vial of phospho-pentoxide as a desiccant. The peptides were weighed 
within an hour after lyophilisation on a 6 decimal scale (Metler Toledo), containing a vial of 
phospo-pentoxide placed 60 minutes prior to weighing. The pre-weighed vials containing the 
peptides’ weight were recorded every minute, for 12 minutes, and the last three recordings 
were averaged for the accurate mass of the peptides. The peptides were stored at ambient 
temperature in a desiccator containing phospho-pentoxide before CD analysis. 
 5.3.1.2 The effect of concentration on the structure of the peptides 
As discussed in Chapter 4, protein concentration has a major effect on the aggregation of 
cytochrome b5. We investigated the concentration effect using the wild-type decapeptide 
(IITTIDSNSS), corresponding to the membrane anchoring domain, and a modified control 
decapeptide (LLSSLKAVAV) (GL Biochem LTD, Shanghai). Peptides were dissolved in 1 
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mL 20% acetonitrile in water. This stock solution was diluted to 200.0 µg/mL and 600.0 
µg/mL solutions for both the wild-type and the control peptides. These solutions, 100 µL, 
were carefully transferred to a 0.5 mm quartz cuvette and subjected to CD analyses on 
Applied Photosystems Chirascan Plus spectropolarimeter. The instrument settings were as 
follows: scan range from 260 – 185 nm; bandwidth, 0.5 nm increment; scanning time per 
point, 0.5 seconds/point; temperature, 20°C; with three repeats per analyses. 
 5.3.1.3 The effect of ionic strength on the structure of the peptides 
It was previously shown that the ionic strength plays a pivotal role in the complex formation 
of cytochrome b5. The effect of ionic strength on the structure of the two peptides, was 
investigated by making dilutions with diluents of increasing ionic strength. Using a sodium 
phosphate buffer (pH 7), the peptide stock solutions were diluted to 200 µg/mL with 
solutions containing 10, 30, 60 and 80 mM phosphate buffer respectively (see table 1). These 
solutions were incubated for 15 minutes at ambient temperature followed by CD analysis 
under the same conditions as described earlier. 
Table 1: Preparation of the different salt concentrations used to study the effect of ionic 
strength on peptide structure. The buffer stock concentration was 100 mM. 
[Phosphate buffer] 10 mM 30 mM 60 mM 80 mM 
Buffer (µL) 10 30 60 80 
20% ACN (µL) 70 50 20 0 
Wild-type peptide Stock (µL) 20 20 20 20 
Buffer (µL) 16 48 96 128 
20% ACN (µL) 124 92 44 12 
Control peptide Stock (µL) 20 20 20 20 
 
5.3.2  Association of the peptides with cytochrome b5 
To investigate whether the synthesised peptide associated with the purified protein, an in 
vitro study with the components was developed. A modified enzyme-linked immunosorbant 
assay (mELISA) was developed for this study. 
The mELISA developed for the purpose of this study is shown in figure 5.1. The protein, 
cytochrome b5, was immobilised on an ELISA Nunc® 96-well microtiter plate, followed by 
the addition of a biotinylated control or wild-type peptide (peptide from GL Biochem LTD, 
Shanghai). If the hinge region is involved in cytochrome b5 aggregation, the biotinylated 
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peptide will associate with the hinge region of the immobilised hemoprotein. An avidin 
labelled horseradish peroxidase (HRP) is added to associate with the biotin labelled peptide 
and the amount of peptide immobilised can be quantified by the increase in absorbance at 405 
nm after addition of substrate for HRP.   
 
Figure 5.1: Schematic representation of the mELISA for cytochrome b5-peptide interaction. 
The assay involves the immobilisation of cytochrome b5, followed by the 
incubation with a biotinylated-peptide where after the HRP-avidin conjugate is 
applied. An appropriate substrate is added for colorimetric visualisation (Biotin 
and streptavidin has one of the strongest non-covalent interactions known in 
nature. The complex has a calculated dissociation constant (Kd) of 10-14 mol/L 
[82]. 
 
 5.3.2.3 Specificity of biotinylated peptides for cytochrome b5 
Before any experiments could be completed with the wild-type peptide, a number of control 
experiments had to be completed. These controls included an experiment where the 
specificity of the peptide for our protein of interest, cytochrome b5, was investigated. As a 
test for specificity, 25 – 1000 ng of cytochrome b5, lysozyme and BSA were respectively 
immobilised on a NUNCTM 96-well microtiter plate by incubating 200 µL of 50 mM 
carbonate buffer, pH 9.0 containing the appropriate amount of each protein, in each well for 
16 hours at 4° C. After coating the plate with the protein, the solutions were decanted from 
each well and all unoccupied spaces were blocked by adding 200 µL casein buffer (10 mM 
TRIS-HCl, pH 7.6, 0.15 M NaCl, 0.5% casein and 0.02% Thiomersal). After 60 minutes at 
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37°C, the content of each well was decanted and the wells were washed using 200 µL PBS-
Tween-20 (PBS containing 0.1% Tween -20) followed by the addition of 100 µL biotinylated 
peptide (GL Biochem LTD, Shanghai) in PBS (2.7 µg peptide) to each well. The plate was 
incubated for 90 minutes at 37°C, where after all solutions were decanted. The plate was 
subsequently washed 3 times with 200 µL PBS-Tween-20, followed by the addition of 100 
µL Avidin-HRP conjugate (1: 5000 in PBS) to all the wells. The plate was incubated for 
another 60 minutes, solutions was decanted and the plate was washed as described earlier. 
Substrate solution (100 µL of 6 mg 2-2'-azino-di-(3-ethylbenzthiazoline sulfonic acid), 6 µL 
32 % H2O2 in 12 mL citrate buffer, pH 5.0) (ABTS) was added to each well, the solution was 
allowed to react for 15 minutes at 37°C and the absorbance subsequently measured at 405 
nm.  
In addition a constant amount of cytochrome b5 (500 ng) was immobilised as described 
above and the mELISA repeated using the wild-type biotinylated peptide as well as the 
control biotinylated peptide. 
 5.3.2.4 Saturation curve using both wild-type -and control biotinylated peptides 
After establishing that the biotinylated-peptide associates specifically with cytochrome b5, 
saturation studies were performed using the mELISA. Cytochrome b5 and BSA, 1 – 2000 µg, 
were respectively immobilised on a NUNCTM 96-well microtiter plate. For BSA a stock 
solution of 10 mg/mL was used and for the cytochrome b5 a 1 mg/mL stock solution. Where 
necessary, cytochrome b5 was concentrated to ca. 200 µL using a SpeedyVac Sample 
Concentrator. For 600, 1000 and 2000 µg protein, 600, 1000 and 2000 µL of the stock 
solution were used to concentrate.  A detailed description of the protein immobilisation is 
given in Table 2.  
Table 2: Immobilisation protocol for BSA and Cytochrome b5 on a NUNCTM 96-well 
microtiter plate for the mELISA. 
µg Protein Immobilised 1 10 75 150 300 600 1000 2000 
BSA (10 µg/µL Stock) (µL) 0.1 1 7.5 15 30 60 100 200 
Buffer (µL) 200 199 192.5 185 170 140 100 0 
         
Cytochrome b5 (1 µg/µL Stock) (µL)  1 10 75 150 300 200 200 200 
Buffer (µL) 199 190 125 50 0 0 0 0 
*Shaded samples: Samples which were concentrated using SpeedyVac Sample Concentrator.  
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After incubating the plate for 16 hours at 4°C the solutions were decanted and the wells 
treated for 60 minutes, with 200 µL casein buffer to prevent non-specific binding. The casein 
was discarded and the wells were washed once using PBS-Tween-20 followed by the 
addition of the biotinylated peptides in PBS (2.7 µg), as described earlier. Incubation steps 
and substrate addition were performed as described in section 5.3.2.3. 
5.4 Results 
Recently our group investigated complex formation of cytochrome b5, using FRET. It was 
found that the membrane anchoring domain played a pivotal role in the aggregate formation 
of the protein. From these findings, through different mutations in the membrane anchoring 
domain, it was deduced to use the portion of the membrane anchoring domain identified as 
IITTIDSNSS. From the sequence of the wild-type peptide containing branched amino acids 
on the N-terminus side would be more prone to beta-sheet formation. As for most beta-sheet 
peptides, this peptide was also found to be quite insoluble in water, which resulted in the use 
of 20% acetonitrile to solubilise the peptide. The control peptide (LLSSLKAVAV), however, 
was designed with conservative mutations on the N-terminus to be more prone to form alpha-
helices and random structures. Also, the C-terminus of the peptide was mutated to limit 
hydrogen bonding of side chains, as well as electrostatic interactions with cationic groups. 
5.4.1 Circular dichroism of Peptides 
The ellipticity values obtained for each sample in the CD spectrum are in millidegrees 
ellipticity (θ). These values can be standardised and expressed, either as molar ellipticity ([θ]) 
or as the mean residue ellipticity. The former can be calculated using the molar concentration 
of each solution, its ellipticity at each wavelength (λ) and the path length of the cuvette. The 
equation for this conversion is given by: 
θmolar, λ 
θ  100
  
 
 
where [M] is the molar concentration of the peptide and l is the path length of the cuvette in 
centimetres. Molar ellipticity, [θ], is given in degrees cm2 dmol-1. 
The secondary structure of protein and peptides can be studied using CD [83]. Secondary 
structures such as α-helices, β-sheets, etc. yield different CD spectra as can be seen in figure 
5.2. Even random/irregular structures can be detected using this method. 
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Figure 5.2: Circular dichroism spectra for various protein secondary structures. Spectra 
represent: solid line, α-helix; long dashed line, anti-parallel β-sheet; dotted line, 
type 1 β-turn; crossed dashed line, extended 310-helix or poly (Pro) II helix and 
short dashed line, irregular structure [83]. 
 5.4.2 Effect of concentration on the structure of peptides 
Figures 5.3 and 5.4 shows the CD spectra for the wild-type and control peptides at low 
peptide concentrations (200 µg/mL) and at relatively high peptide concentrations (600 
µg/mL). The CD spectra (figure 5.3) indicate that both peptides at 200 µg/mL are represented 
by irregular structures in PBS. Such irregular structures are characterised by an intense 
ellipticity minimum at ~195 nm (refer to figure 5.2). For the wild-type peptide two different 
minima could be observed. As for the control peptide, the minimum at 195 nm indicated the 
presence of irregular structures, however, the intensity was 50% less than that of the wild 
peptide. This indicated the wild-type peptide had less irregular structures.  The shoulder 
minimum at ~220 nm, indicated a secondary structure such as a β-sheet or an α-helix. 
However, as this wild-type peptide contains Thr and Ile which both have β-branched side 
chains that do not permit α-helices, it is more plausible that the ordered structures may be β-
sheets. The fact that the wild-type peptide was quite difficult to get into solution and tended 
to form aggregates also pointed to a tendency to form β-sheet structures which tend to be less 
soluble. 
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Figure 5.3: Far UV CD spectra for the wild-type and control peptides (200 µg/mL). Orange 
and blue solid line represents CD data for wild-type and control peptides, 
respectively.  
 
 
Figure 5.4: Far UV CD spectra for the wild-type and control peptides (600 µg/mL). Also 
shown on secondary y-axis is the absorbance of each peptide. Orange and blue 
solid line represents CD data for wild-type and control peptides respectively, 
while dashed line represents their absorbance. 
 5.4.3 The effect of ionic strength on the structure of the peptides 
By dissolving the peptides in solutions containing increasing concentrations of phosphate 
buffer, it was observed that the difference in ionic strength had a slight effect on the CD 
spectrum of peptides. This was in contrast to what was found in the previous chapter using 
the ANS dye and purified cytochrome b5. It was expected that the wild-type peptide would 
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show signs of more organised structure as the ionic strength was increased. For both the 
peptides there was a slight loss in the 195 nm ellipticity at about 10% for the wild-type 
peptide and >20% for the control peptide (Figures 5.5 and 5.6). As the wild-type peptide was 
already more ordered than the control peptide the change in ionic strength probably had less 
of an affect. The control peptide adapted more ordered structures in the higher ionic strength 
buffers, as such an ionic environment leads to dehydration.   
 
 
Figure 5.5: Far UV CD spectra for the wild-type peptide (200 ug/mL). The peptide was 
titrated with solutions of increasing ionic strength (10 – 80 mM phosphate 
buffer). 
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Figure 5.6: Far UV CD spectra for the control peptide (200 ug/mL). The peptide was titrated 
with solutions of increasing ionic strength (10 – 80 mM phosphate buffer). 
5.4.4 Association of biotinylated-peptides with cytochrome b5 
Interaction of both the wild-type and the control peptides with 500 ng of immobilised 
cytochrome b5 was tested using the mELISA and biotinylated versions of the two peptides. 
(figure 5.7). It is clear that the control peptide has a significantly lower attraction (P=0.012) 
for the cytochrome b5 than the wild-type peptide.  
 
Figure 5.7: Affinity of biotinylated-peptides for immobilised cytochrome b5. Biotinylated-
peptides (2.7 µg) were incubated with 500 ng immobilised cytochrome b5 where 
after streptavidin-HRP conjugate (1: 5000) was added. Wt-Peptide; wild-type 
peptide, C-Peptide; control peptide, No Peptide; No peptide added to 500 ng 
cytochrome b5 and Buffer; no cytochrome b5 immobilised. 
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The specificity of the wild-type peptide for cytochrome b5 was also determined by using 
cytochrome b5, lysozyme and BSA (Figure 5.8).  
As expected, there is a non-specific concentration independent interaction between the BSA 
and lysozyme and the biotinylated peptide. This could be due to non-specific hydrophobic 
interactions with BSA and its hydrophobic pockets and the increase in absorbance for the 
lysozyme could be a result of this cationic protein interacting with the anionic peptides. 
However, as the amount of protein was increased, only the signal for the cytochrome b5 
increased in a concentration-dependent manner indicating a higher affinity specific 
interaction between the wild-type peptide and cytochrome b5 (figure 5.8). The concentration 
depended increase of cytochrome b5 could indicate that much more specific electrostatic 
interactions, such as hydrogen bonding, could be in play, rather than hydrophobic and ionic 
interactions. These bonds are probably hidden and quite stable and not disrupted by the 
detergent wash steps, as for the non-specific binding which occurred between the peptide and 
the control proteins. 
 
 
Figure 5.8: Specificity of biotinylated wild-type peptide. The biotinylated-peptide (2.7 µg) 
was incubated with increasing amount of different proteins (indicated in legend). 
The presence of the bound biotinylated-peptide was determined using 
streptavidin-HRP conjugate (1: 5000). 
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 5.4.5 Saturation curve using both wild-type -and control biotinylated peptides 
Establishing that the peptide associates with cytochrome b5, we investigated whether binding 
saturation could occur at 37°C by increasing the amount of antigen and keeping the ligand 
(biotinylated-peptide) concentration constant. As shown in figure 5.9, both the wild-type and 
the control peptides reached saturation. This indicated that the N-terminus sequence of the 
wild-type peptide IITTI and the conservatively mutated control peptide sequence of LLSSL, 
may both be able to interact with cytochrome b5, possibly via hydrogen-bonding with the 
hydroxyl groups in the side chains. The C-terminus sequence of the wild-type and control 
peptides are very different namely DSNSS and KVAVAV, respectively. The C-terminus of 
the wild-type peptide can form multiple hydrogen bonds, while that of the control peptide can 
form non-specific hydrophobic interactions. Also, the cationic control peptide may have 
electrostatic interaction with the Asp in the hinge region. It was, however, clear that the wild-
type peptide reached higher saturation values at a lower immobilised protein amount with 
50% saturation reached at 399 µg immobilised cytochrome b5 versus 540 µg for the control 
peptide.  No increase in baseline association was observed for the BSA control protein with 
either control or the wild-type peptide. 
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Figure 5.9: Saturation binding curves of biotinylated-peptides. Biotinylated-peptides (2.7 µg) 
were added to increasing amounts of immobilised protein. The presence of the 
biotinylated-peptide was determined using streptavidin-HRP conjugate (1: 5000) 
in duplicate analyses.  
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5.5 Conclusion 
Our group has shown that the full length form of cytochrome b5 is able to form multimeric 
complexes [3] when purified as described in literature [4]. Lombard et al. [3] showed that 
these multimeric complexes are dependent on the membrane anchoring domain. The 
investigators showed, by purifying cytochrome b5 from ovine liver and analysing the purified 
fraction using both SDS-PAGE and high performance gel permeation chromatography (HP-
GPC), multimeric complexes could be observed. Furthermore it was shown, when removing 
the membrane anchoring domain through tryptic digestion, that the appearance of these 
multimeric complexes was abolished [3].  
In general small non-constrained peptides show very little organised structure in normal 
buffers. We also observed, using CD, that the two decapeptides in the study had 
predominantly unordered structures. However, when the two peptides were directly 
compared, the wild-type peptide had more ordered structure, possibly β-sheets, with less of 
an irregular structure than that of the control peptide. Titration of the peptides using sodium 
phosphate salt had very little effect on the structure of the wild-type peptide (figure 5.5). 
Conversely, the control peptide showed that as the salt concentration increased, less irregular 
structure was observed (figure 5.6). In the fluorescent studies (Chapter 4), we observed that 
the ionic strength had a definite effect on the aggregation. This was, as the ionic strength 
increased so did the aggregation (section 4.2.4). For those studies it was necessary to increase 
the salt concentrations to more than 500 mM. Unfortunately, such high concentrations cannot 
be reached using CD as this would result in interference in the far UV region. 
We investigated whether or not the synthetic peptides were able to associate with purified 
cytochrome b5 in vitro. The wild-type peptide interacted significantly (P=0.012) better with 
cytochrome b5 than the control peptide (figure 5.7). This interaction was also highly specific 
for cytochrome b5, with no specific affinity for BSA or lysozyme (figure 5.8). From figure 
5.9 it can be seen that both the wild-type and the control peptide had saturating binding to 
immobilised cytochrome b5, but the control peptide had a lower affinity and bound to a lesser 
extent. These results revealed that the wild-type peptide had a specific affinity for the purified 
cytochrome b5, which probably depended on a hydrogen bond network.  
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Chapter 6  
Conclusion 
Cytochrome b5 can be found in various mammalian tissues as a soluble cytosolic protein, 
consisting of 98 amino acids expressed primarily in erythrocytes, as well as an amphipathic 
membrane bound protein. The amphipathic membrane bound cytochrome b5 is divided into 
two types, depending on primary structure and sub-cellular localization. The first, a 134 
amino acids form of cytochrome b5, is found in the endoplasmic reticulum and is the only 
form known to significantly affect adrenal steroidogenesis [1], [84]. The second form of 
cytochrome b5 is localized primarily to the outer mitochondrial membrane and consists of 
146 amino [84–88]. 
The influence of microsomal cytochrome b5 on adrenal steroidogenesis, and more 
specifically the 17,20-lyase reaction catalyzed by cytochrome P450 17α-hydroxylase/17,20-
lyase, has become a topic of interest due to the clinical importance of this key steroidogenic 
monooxygenase [89]. Results from our laboratory have also recently shown that cytochrome 
b5 augments the activity of 3β-hydroxysteroid dehydrogenase/∆5-∆4 isomerase, further 
expanding the role of this hemoprotein during steroidogenesis [44], [46].  
Previous studies in our laboratory on the enzymatic properties of ovine cytochrome b5, 
revealed that the enzyme exists in more than one aggregation state in vivo [90].  The aim of 
this investigation was to isolate and purify ovine cytochrome b5 for subsequent identification 
and characterization of the regions in the molecule responsible for the previously observed 
aggregation. 
Cytochrome b5 was previously isolated by Lombard et al. [3] using a PEG fractionation 
method. In this study the same method was employed for the isolation of cytochrome b5 from 
ovine liver. Purification data revealed (Table 3.2) that a 118-fold purification could be 
achieved with a yield of 55%. During the course of this study, the purification method for 
cytochrome b5 had to be scaled up to increase the yield of the protein in order to obtain data 
with physical analytical techniques to further elucidate aggregation. The data gathered 
throughout this purification showed that similar yields could be achieved but that the fold 
purification decreased by more than 50% (Table 3.3). For this study, vast amount of 
cytochrome b5 was needed and the up-scaling of the technique was appropriate. In terms of 
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specific activity, up-scaling is not recommended as there is no increase in the fold 
purification after the second purification step. 
During analysis of a microsomal suspension, using SDS-PAGE, a prominent protein band 
could be observed at ±60 kDa and no apparent protein band could be observed corresponding 
to the reported molecular weight of cytochrome b5 (16 kDa). The SDS-PAGE protein 
profiles for all three the purified fractions, however, showed that cytochrome b5 was purified 
with protein bands corresponding to a molecular weight of 16 kDa (monomer). This protein 
band was accompanied by an additional band corresponding to ± 60 kDa (tetramer) in all 
purified fractions. Other multimeric complexes could also be observed, albeit to a lesser 
extent. These multimeric complexes were recognized by cytochrome b5 antibodies and were 
concluded to be dimers (32 kDa), trimers (48 kDa), etc. In terms of antibody specificity, both 
forms of the protein were recognized. To a larger extend the monomer and the tetramer 
(Figure 3.3). 
The purified protein was subjected to ESI-MS for accurate mass determination. Although 
SDS-PAGE revealed multiple protein bands, MS analysis indicated only a single heme 
containing protein (Figure 3.6). The apo-protein detected had a molecular weight of 15249 
Da (Figure 3.7), similar to that previously reported by Lombard et al. [3]. Due to the absence 
of the higher molecular weight proteins it was concluded that the ionization process in the 
mass spectrometer abolished the existence of all aggregates in solution, thus leaving only a 
monomeric form of the protein to be detected.  
For the preparation of protein samples for separation using SDS-PAGE, the protein solution 
is treated with a treatment buffer containing both sodium dodecyl sulphate and 2-
mercaptoethanol. The former is an anionic detergent, which disrupts non-covalent bonds 
present in protein resulting in the loss of protein conformation, while the latter is a reducing 
agent responsible for breaking disulphide bonds. Even with these two components present in 
the treatment buffer, the multiple bands for purified cytochrome b5 on the polyacrylamide gel 
persisted. The same results were obtained through the addition of a third denaturing agent, 
8M urea, together with denaturing conditions commonly used for preparing membrane bound 
proteins for SDS-PAGE analyses. During the investigation of different denaturing conditions, 
human phosphopantothenoyl cysteine decarboxylase was included as control. This protein 
exists as a homomeric trimer with a molecular weight of 75 kDa [91]. Using conventional 
denaturing conditions it was possible to fully denature this trimer protein into its monomeric 
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form and this could be observed at a molecular weight of 25 kDa on the polyacrylamide gel 
(Figure 4.1). These results further confirmed that cytochrome b5 formed specific highly 
stable tetrameric aggregates. 
Immunological studies revealed that the antibodies, raised specifically against the aggregate 
from of cytochrome b5, showed affinity for only the aggregated state while the antibodies 
raised against the monomeric form recognised both the monomer and the aggregate (Figure 
4.2). This was in contrast to what was found by Storbeck [6] who showed that the antibodies 
raised against the aggregate recognised both forms of the protein while the monomeric 
antibody only recognised the monomer. There can be two possible explanations for this 
finding: (a) because both the monomeric and aggregate antibodies were isolated from the 
same immune serum, the chances for cross recognition were high and almost inevitable and 
(b) because titres were not determined, isolation of these specific antibodies with the use of 
only three steps, as described by Lombard et al. [3], could also lead to cross contamination if 
three isolation steps are not sufficient. 
A further investigation of the proteins in the two bands (corresponding to 16 and 60 kDa 
respectively), observed during SDS-PAGE analyses of cytochrome b5, included the excision 
of the protein bands from the SDS-PAGE gel and identification of the proteins using MS/MS. 
The excised bands were digested with trypsin and the resulting peptides were identified using 
a database search (Matrix Science - Mascot MS/MS Ions Search). Both the bands, 
corresponding to the molecular weights of 16 and 60 kDa, were identified to have peptide 
sequences indicative of cytochrome b5. These bands were identified with a high degree of 
certainty as the results obtained had Mascot Scores well above 20 (a score of 20 and above 
considered to be significant) (Table 4.1) [92]. These results confirmed that the denaturing 
process commonly used for SDS-PAGE analyses did not fully dissociate the aggregates 
formed by cytochrome b5 and confirmed earlier observations by Lombard et al. [3]. 
Previously the effect of ionic strength on aggregation was investigated [3]. Using high 
performance gel permeation chromatography (HP-GPC), Lombard et al. [3] showed that two 
peaks could be observed when analysing purified cytochrome b5. Both these peaks exhibited 
typical cytochrome b5 spectral properties. Changing the mobile phase to PBS, they found that 
only the single peak could be observed. This peak had the same retention time as that of the 
higher molecular weight (64 kDa) form of the protein. 
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In our study we investigated the effect of ionic strength on purified cytochrome b5 using 
fluorescence. A fluorescent dye, 1-anilinonaphthalene-8-sulfonic acid (ANS), was used 
which fluoresces when exposed to hydrophobic areas. Preliminary studies showed that a 
definite increase in the fluorescence could be observed for cytochrome b5 as the protein 
concentration was increased (Figure 4.4) while the fluorescence for cytochrome C remained 
at a basal level under similar conditions (Figure 4.5). This observation indicated that the 
aggregated form of the protein was present. In addition, by incubating 100 µg cytochrome b5 
in different buffer solutions, with ionic strengths ranging from 5 mM – 1000 mM, an increase 
in the aggregation state of cytochrome b5 was observed as the ionic strength of the solution 
containing the protein was increased (Figure 4.7). This finding supported previous studies [3] 
which stated that the aggregation of the protein is dependent on the ionic strength.   
The effect of protein concentration on the aggregation of cytochrome b5 was also 
investigated using the same fluorescent dye. Investigating the aggregation of cytochrome b5 
using this dye has never been previously reported. An increase in the fluorescence could be 
shown with an increase in protein concentration, indicating a direct relationship between 
protein concentration and protein aggregation. No concentration dependent increase in 
fluorescence could be observed for the control cytochrome C under identical conditions 
(Figure 4.6). 
During previous studies on cytochrome b5, Lombard et al. [3] showed that the hydrophobic 
membrane anchoring domain plays a crucial role on cytochrome b5’s aggregation. This 
domain is susceptible to certain proteases and can be removed through trypsin digestion. 
Lombard et al. showed that, by removing this domain, the protein remained functionally 
active but, when analysed using SDS-PAGE, aggregation was completely abolished [3]. 
Using a truncated form of cytochrome b5, prepared as described by Lombard et al., together 
with the ANS fluorescence dye, no fluorescence could be detected with an increase in protein 
concentration (Figure 4.8). This result agreed with the findings of Lombard et al. and 
confirmed the role of the membrane anchoring domain in aggregation [3].  
Recently, Storbeck et al. [6] showed that cytochrome b5 forms aggregates in vivo. Using 
fluorescence resonance energy transfer (FRET), it was confirmed that the membrane 
anchoring domain is involved in the aggregation. By making certain mutations in the 
membrane anchoring domain, they were able to decrease the FRET signal significantly. The 
decrease in FRET provided sufficient evidence that this domain is involved in protein self 
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association. In this study, the membrane anchoring domain was investigated using a ten 
amino acid peptide and a control peptide. This decapeptide corresponded to a portion within 
the membrane binding domain. Circular dichroism was used to study the secondary structure 
of this peptide. We found that the wild-type peptide had 50% less irregular structure (Figures 
5.3 and 5.4) than a control peptide (Figures 5.3 and 5.4). Also, structural analysis of the wild-
type peptide included the appearance of secondary structures such as β-sheets and/or α-
helices. Due to structural roles of Thr and Ile side chains, which contain β-branched side 
chains, it was concluded that the secondary structure observed could possibly be β-sheets 
rather than α-helices. None of these secondary structures were present in the control peptide. 
The effect of ionic strength on the secondary structure of the peptides was also investigated. 
Unfortunately, no significant difference could be observed for either peptide (Figures 5.5 and 
5.6). This was in contrast with what was found in the fluorescence study. It is, however, 
important to note that in the fluorescent studies the ionic concentrations exceeded 500 mM. 
At such high ionic concentrations CD analyses could not be accomplished as a result of 
interference in the far-UV spectrum. 
Association studies, using a modified ELISA technique, revealed that the peptide indeed 
associated with the purified protein in a specific manner. Binding studies revealed that 
saturation could be reached and that the wild-type peptide had a significantly lower 
dissociation constant than the control peptide (Figure 5.9). We found that the wild-type 
peptide had a significantly better interaction with cytochrome b5 than the control peptide. 
Furthermore, it was concluded that the interaction of the wild-type peptide is probably much 
more specific which is accomplished through hydrogen bonding. Binding studies also 
revealed that association of the control peptide with cytochrome b5 could be observed. This 
observation, however, showed that the wild-type peptide had higher saturation values and 
50% saturation occurring at less than 25% immobilised cytochrome b5. Recently, using 
FRET, Storbeck et al. [6] also showed that the hydrophobic C-terminus plays a pivotal role in 
the protein’s aggregate formation. The findings from this study concurred with Storbeck’s 
conclusion, and the information gathered in the studies, using this peptide, strongly suggests 
that the hydrophobic membrane domain plays a specific role in the aggregation of 
cytochrome b5.  
In this study we investigated the complex formation of cytochrome b5. The protein was 
isolated from ovine liver and partially characterised. The multiple bands present in SDS-
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PAGE analyses showed us that the aggregated state of the protein was stable and could not be 
disrupted using conventional denaturing conditions. Furthermore, it was found that this 
aggregated state can be manipulated using either protein concentration and/or ionic strength. 
It was mentioned earlier that the membrane anchoring domain plays a role in the protein’s 
aggregation and using a peptide corresponding to this region it was shown that this indeed 
was the case. This was accomplished through structural analyses and binding studies. This 
study also revealed that there was interaction between the peptide and the purified protein. 
This provided further evidence that the hydrophobic membrane anchoring domain plays a 
central role in the aggregation of cytochrome b5.  
Cytochrome b5 is involved in a number of biological reactions. During these reactions it 
either provides the second, rate limiting electron to cytochrome P450 enzymes or cytochrome 
b5 enhances the activities of enzymes through an allosteric effect. Furthermore, there are 
several hypotheses postulated on how cytochrome b5 interacts with the enzymes which it 
augments. During the discussions of these hypotheses, it was concluded by a number of 
researchers that cytochrome b5 forms hetero-dimeric complexes with cytochrome P450 
enzymes [1][90]. These complexes are described for both electron transfer reactions as well 
as allosteric effectors. 
Our group has been isolating cytochrome b5 from animal tissue for a number of years and has 
observed and studied the aggregation for those years. In 2002, Lombard et al. raised the 
question “Sheep adrenal cytochrome b5: active as a monomer or a tetramer in vivo?” [3]. 
Apart from criticism that the aggregation was a result from the manner in which cytochrome 
b5 was isolated in our laboratory, it was also considered whether the protein could use this 
self association as a regulatory system in vivo.  When Storbeck et al. [6] showed that 
cytochrome b5 aggregation could also be observed when expressed in living cells, it was 
confirmed that cytochrome b5 aggregation occurred in vivo and was not due to the isolation 
procedures followed in our laboratory. 
The proposed mechanisms of action of cytochrome b5 are rather complex and discussed 
comprehensively in Chapter 2. During electron transfer reactions, it is considered that 
cytochrome b5 and cytochrome P450 form a two electron acceptor complex through charge 
pairing [1]. In addition, during allosteric stimulation, it is believed that cytochrome b5 and 
cytochrome P450 form a hetero-dimeric complex through charge pairing [1][90]. 
Investigating the aggregation of cytochrome b5 could therefore shed light on how 
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cytochrome b5 influences cytochrome P450-dependent reactions. The aggregation of 
cytochrome b5 can act as a regulatory mechanism. Self-association would inhibit 
augmentation of cytochrome P450-catalysed reactions as the formation of homomeric 
complexes prevents the cytochrome b5 forming heterodimeric complexes with cytochrome 
P450. Therefore, it can be considered that the monomeric form of cytochrome b5 would 
generally be considered the active form while the aggregated complex is the inactive form. 
By considering that cytochrome b5 utilises this aggreagation as a method to switch between 
its active and inactive form, this could hugely impact on the steroid output in adrenal 
steroidogenises. This aggregation can thus be said to be a mechanism to control its 
association with P450 enzymes and 3βHSD which will, ultimately, influence the output of 
sex steroids, mineralocorticoids and glucocorticoids. 
In this study we showed that self association can be manipulated using either protein 
concentration or ionic strength and that the membrane anchoring domain plays an important 
part in the formation of specific tetrameric complexes. Hence, it can be considered that the 
cell can employ these aggregation properties of cytochrome b5 as means of switching 
between the active and inactive forms. 
Future studies on the aggregation of cytochrome b5 should investigate means to prove 
beyond doubt that aggregation is indeed used as a regulatory system for cytochrome b5 
augmentation of cytochrome P450-catalysed reactions. These investigations could involve the 
permanent cross linking of cytochrome b5 monomers and investigating its function as an 
effector for cytochrome P450 reactions.  In addition a physiological trigger for the 
aggregation and de-aggregation of cytochrome b5, coupled to a hormone signalling event, 
needs to be found in order to explain the differentiated effect of cytochrome b5 on 
cytochrome P450-dependent reactions in different tissues.  
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